1. Field of the Invention
The present invention relates generally to a method for forming on a substrate an arsenosilicate glass (ASG or AsSG) film with a cap film.
2. Related Art
Metal-oxide-semiconductor field effect transistors (MOSFETs) are fundamental switching devices to perform logic operations in large scale integrated circuits (LSIs). As the downsizing of MOSFETs progress, decrease in junction depth (Xj) and increase in doping concentration are indispensable in the scaling trend. FinFETs and Tri-gate FETs have fin structures for source/drain extension, and such devices require reduction of lateral resistance (or sheet resistance) of the source/drain extension regions to obtain larger drain current by scaling down of MOSFETs. Therefore, both shallow Xj (Xj is defined as the depth where dopant concentration is 5×1018/cm3) and low sheet resistance (Rs) of the source/drain extension regions are indispensable for further scaling down of MOSFETs. However, reducing Rs at shallow regions (e.g., Xj<10 nm) has not been successful. The above characteristics also are important to turn-on voltage-modulation by Ground-Plane (GP) technique for Tunnel Field-Effect Transistor (TFET).
Any discussion of problems and solutions in relation to the related art has been included in this disclosure solely for the purposes of providing a context for the present invention, and should not be taken as an admission that any or all of the discussion was known at the time the invention was made.
Some embodiments provide a method for providing a thin film having a sheet resistance (Rs) of less than 1,000 ohm/sq with a junction depth (Xj) of less than 10 nm (preferably, an Rs of less than 500 ohm/sq with an Xj of less than 5 nm). In some embodiments, an arsenosilicate glass (ASG) film using arsenic (As) as n-type dopant is used in combination with a SiN cap, wherein a surface of the ASG film is treated in situ with a particular gas before forming the SiN cap. In some embodiments, the gas used for treating the surface of the ASG film is a combination of nitrogen gas, silane gas, hydrogen gas, and a noble gas. In some embodiments, the SiN cap is formed by plasma-enhanced atomic layer deposition (PEALD). In some embodiments, the ASG film is formed using solid-state doping. In some embodiments, the doping method is suitable for extension-doping in FinFETs or ground-plane doping in TFETs. In accordance with further exemplary embodiments, a method of realizing an Rs of less than 1,000 ohm/sq with an Xj of less than 10 nm is provided.
For purposes of summarizing aspects of the invention and the advantages achieved over the related art, certain objects and advantages of the invention are described in this disclosure. Of course, it is to be understood that not necessarily all such objects or advantages may be achieved in accordance with any particular embodiment of the invention. Thus, for example, those skilled in the art will recognize that the invention may be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objects or advantages as may be taught or suggested herein.
Further aspects, features and advantages of this invention will become apparent from the detailed description which follows.
These and other features of this invention will now be described with reference to the drawings of preferred embodiments which are intended to illustrate and not to limit the invention. The drawings are greatly simplified for illustrative purposes and are not necessarily to scale.
In this disclosure, “gas” may include vaporized solid and/or liquid and may be constituted by a single gas or a mixture of gases. In this disclosure, a process gas introduced to a reaction chamber through a showerhead may be comprised of, consist essentially of, or consist of a silicon-containing gas and an additive gas. The silicon-containing gas and the additive gas can be introduced as a mixed gas or separately to a reaction space. The silicon-containing gas can be introduced with a carrier gas such as a noble gas. A gas other than the process gas, i.e., a gas introduced without passing through the showerhead, may be used for, e.g., sealing the reaction space, which includes a seal gas such as a noble gas. In some embodiments, “film” refers to a layer continuously extending in a direction perpendicular to a thickness direction substantially without pinholes to cover an entire target or concerned surface, or simply a layer covering a target or concerned surface. In some embodiments, “layer” refers to a structure having a certain thickness formed on a surface or a synonym of film or a non-film structure. A film or layer may be constituted by a discrete single film or layer having certain characteristics or multiple films or layers, and a boundary between adjacent films or layers may or may not be clear and may be established based on physical, chemical, and/or any other characteristics, formation processes or sequence, and/or functions or purposes of the adjacent films or layers.
Further, in this disclosure, the article “a” or “an” refers to a species or a genus including multiple species unless specified otherwise. The terms “constituted by” and “having” refer independently to “typically or broadly comprising”, “comprising”, “consisting essentially of”, or “consisting of” in some embodiments. Also, in this disclosure, any defined meanings do not necessarily exclude ordinary and customary meanings in some embodiments.
Additionally, in this disclosure, any two numbers of a variable can constitute a workable range of the variable as the workable range can be determined based on routine work, and any ranges indicated may include or exclude the endpoints. Additionally, any values of variables indicated (regardless of whether they are indicated with “about” or not) may refer to precise values or approximate values and include equivalents, and may refer to average, median, representative, majority, etc. in some embodiments.
In the present disclosure where conditions and/or structures are not specified, the skilled artisan in the art can readily provide such conditions and/or structures, in view of the present disclosure, as a matter of routine experimentation. In all of the disclosed embodiments, any element used in an embodiment can be replaced with any elements equivalent thereto, including those explicitly, necessarily, or inherently disclosed herein, for the intended purposes. Further, the present invention can equally be applied to apparatuses and methods.
The embodiments will be explained with respect to preferred embodiments. However, the present invention is not limited to the preferred embodiments.
In some embodiments, a method for forming on a substrate a doped silicon oxide film with a cap film, comprises: (i) forming an arsenosilicate glass (ASG) film as an arsenic (As)-doped silicon oxide film on a substrate; (ii) continuously treating a surface of the ASG film with a treating gas constituted by Si, N, and H without excitation; and (iii) continuously forming a silicon nitride (SiN) film as a cap film on the treated surface of the ASG film. By using the ASG film, in place of phosphorus-doped silicon dioxide glass (PSG) film, in combination with the SiN cap in place of a SiO cap, and treating in situ a surface of the ASG film with the treating gas prior to depositing the SiN cap thereon, a structure where a sheet resistance (Rs) is as low as 1,000 ohm/sq (preferably 500 ohm/sq or less), and a junction depth (Xj) (as the depth of 5E+18 atom/cm3) is as small as 10 nm (preferably 5 nm or less) can be fabricated, indicating that the concentration of dopant (As) is high only in a top surface of the substrate at the interface (i.e., high concentration and shallow diffusion of dopant into the substrate). In some embodiments, the in-film concentration of As in the ASG film is approximately 1E+22 atom/cm3. Conventionally, it was not successful to reduce Rs when Xj was as small as 10 nm. Arsenic does not diffuse as much in a silicon substrate as does phosphorus, thereby contributing to a small junction depth, and also, the SiN cap blocks diffusion of As more than does a SiO cap if the interface is not exposed to air, thereby contributing to higher concentration of As on the substrate side than the cap side. Without being limited by the theory, as a result, both a low Rs and a low Xj can be achieved according to some embodiments. In this disclosure, the “ASG” film and “SiN” film can contain impurities including unavoidable elements to the extent accepted by one of ordinary skill in the art as an “ASG” film and “SiN” film, respectively. In some embodiments, the substrate is a silicon wafer or has an underlying semiconductor layer such as a silicon layer.
In some embodiments, a sheet resistance (Rs) and an As junction depth (Xj) at an interface between the ASG film and the substrate after an annealing step are approximately 500 ohm/sq or less (e.g., 100 ohm/sq to 400 ohm/sq), and approximately 5 nm or less (e.g., 1 nm to 4 nm), respectively.
In this disclosure, the word “continuously” refers to at least one of the following: without breaking a vacuum, without being exposed to air, without opening a chamber, as an in-situ process, without interruption as a step in sequence, without changing process conditions, and without causing chemical changes on a substrate surface between steps, depending on the embodiment. In some embodiments, an auxiliary step such as purging or other negligible step in the context does not count as a step, and thus, the word “continuously” does not exclude being intervened with the auxiliary step. By continuously conducting steps (i) through step (iii), the surface of the ASG film is treated with the treating gas fully without being exposed to air or any other oxygen-containing atmosphere throughout steps (i) to (iii), so that the high concentration of dopant can be maintained in the ASG film. In some embodiments, steps (i) to (iii) are conducted in a same reaction chamber. Accordingly, productivity can significantly be improved. Since step (ii) is conducted without exciting gases, substantially no film is formed on the surface of the ASG film, but gases are adsorbed on the surface of the ASG film. By way of step (ii), the interface between the ASG film and the SiN cap can effectively block diffusion or migration of As from the ASG film toward the SiN cap. A combination of Si, N, and H included in the treating gas is effective because these gases can be used for SiN cap formation and their flow can fully be stabilized before the SiN cap formation starts.
In some embodiments, all the gases including the treatment gas used in step (ii) are identical to all the gases used in step (iii), so that step (ii) and step (iii) can continuously be conducted without any interruption or any intervention therebetween, thereby not only increasing productivity but also forming the SiN cap layer having a more effective interface for blocking diffusion of the dopant. In some embodiments, all the gases including the treatment gas used in step (ii) are identical to all the gases used in step (iii) not only in kind but also in quantity (flow rate). In some embodiments, in step (ii), the treating gas is supplied with a noble gas such as helium (He), neon (Ne), argon (Ar), krypton (Kr), and/or xenon (Xe). In some embodiments, the treating gas in step (ii) comprises N2 gas, SiH4 gas, and H2 gas, or other silicon-containing gas such as Si2H6 and other nitrogen- and hydrogen-containing gas such as NH3. Due to the surface treatment, gas feeds for the SiN cap formation can effectively be stabilized before starting the SiN cap formation, and changing the recipe for the SiN cap formation (mainly changing the setting of a plasma generator) can smoothly be accomplished.
In some embodiments, the concentration of As in the ASG film is approximately 1E+22 atom/cm3, and the thickness of the ASG film formed in step (i) is approximately 5 nm or less (typically 0.5 nm to 5 nm).
In some embodiments, in step (i), the ASG film is formed by atomic layer deposition (ALD) with solid-state doping. In some embodiments, the solid-state doping is conducted at a temperature of approximately 300° C. or lower. In some embodiments, the ALD is a plasma-enhanced ALD. In some embodiments, the solid-state doping is conducted based on the disclosure of U.S. Patent Application Publication No. 2013/0115763, the disclosure of which is herein incorporated by reference in its entirety. Any suitable method of forming an ASG film, including any conventional methods such as plasma doping, ion-assisted deposition and doping (IADD), spin-on coating, sub-atmospheric pressure chemical vapour deposition (SACVD), or ALD, can be used in some embodiments.
In some embodiments, the thickness of the SiN film formed in step (iii) is approximately 5 nm or less (typically 0.5 nm to 5 nm). In some embodiments, the SiN film is deposited by atomic layer deposition (ALD). In some embodiments, the ALD is a plasma-enhanced ALD. Any suitable method of forming a SiN cap, including any conventional methods such as low-pressure CVD or PEALD (such as U.S. Patent Application Publication No. 2014/0141625 and No. 2013/0330933, each disclosure of which is herein incorporated by reference in its entirety), can be used in some embodiments.
In some embodiments, the method further comprises, after step (iii), annealing the SiN film formed on the ASG film. In this disclosure, “annealing” refers to a process which dopant such as phosphorous or arsenic is diffused into the silicon substrate.
In some embodiments, the ASG film may be formed as a solid-state doping (SSD) layer by PEALD, one cycle of which is conducted under conditions shown in Table 1 below.
The dopant precursor may be provided with the aid of a carrier gas. Since ALD is a self-limiting adsorption reaction process, the number of deposited precursor molecules is determined by the number of reactive surface sites and is independent of the precursor exposure after saturation, and a supply of the precursor is such that the reactive surface sites are saturated thereby per cycle.
In some embodiments, an arsenosilicate glass ALD cycle comprises a silicon phase, a dopant phase and an oxidation phase. The silicon phase comprises providing a pulse of BDEAS to a reaction chamber comprising a substrate. Excess BDEAS is removed and the substrate is contacted with a pulse of a dopant precursor in the dopant phase. Excess dopant precursor and reaction by-products, if any, are removed. The substrate is then contacted with oxygen plasma to form a boron or phosphorous-arsenosilicate glass. The oxygen plasma may be generated in situ, for example in an oxygen gas that flows continuously throughout the ALD cycle. In other embodiments the oxygen plasma may be generated remotely and provided to the reaction chamber.
As mentioned above, each pulse or phase of each ALD cycle is preferably self-limiting. An excess of reactants is supplied in each phase to saturate the susceptible structure surfaces. Surface saturation ensures reactant occupation of all available reactive sites (subject, for example, to physical size or “steric hindrance” restraints) and thus ensures excellent step coverage. In some embodiments the pulse time of one or more of the reactants can be reduced such that complete saturation is not achieved and less than a monolayer is adsorbed on the substrate surface. However, in some embodiments the dopant precursor step is not self-limiting, for example, due to decomposition or gas phase reactions.
In some embodiments, the silicon precursor and the dopant precursor are both provided prior to any purge step. Thus, in some embodiments a pulse of silicon precursor is provided, a pulse of dopant precursor is provided, and any unreacted silicon and dopant precursor is purged from the reaction space. The silicon precursor and the dopant precursor may be provided sequentially, beginning with either the silicon precursor or the dopant precursor, or together. In some embodiments, the silicon precursor and dopant precursor are provided simultaneously. The ratio of the dopant precursor to the silicon precursor may be selected to obtain a desired concentration of dopant in the deposited thin film.
The ratio of silicon precursor cycles to dopant precursor cycles may be selected to control the dopant concentration in the ultimate film deposited by the PEALD process. For example, for a low dopant density, the ratio of dopant precursor cycles to silicon precursor cycles may be on the order of 1:10. For a higher concentration of dopant, the ratio may range up to about 1:1 or higher such as 1.5:1, 2:1, 2.5:1, 3:1, 4:1, etc. In some embodiments all of the deposition cycles in an ALD process may be dopant precursor cycles. The ratio of deposition cycles comprising dopant to deposition cycles that do not include dopant (such as the ratio of dopant precursor cycles to silicon precursor cycles, or the ratio of dopant oxide cycles to silicon precursor cycles) may be referred to as the control knob. For example, if one dopant precursor cycle is provided for every four silicon precursor cycles, the control knob is 0.25. If no undoped oxide cycles are used, the control knob may be considered to be infinite.
By controlling the ratio of dopant precursor cycle to silicon precursor cycle, the dopant concentration can be controlled from a density range of about 0 atoms of dopant to about 5E+22/cm3 atoms of dopant. Density may be measured, for example, by SIMS (secondary-ion-probe mass spectrometry).
In addition, the dopant density can be varied across the thickness of the film by changing the ratio of dopant precursor cycles to silicon precursor cycles during the deposition process. For example, a high density of dopant may be provided near the substrate surface (lower ratio of silicon precursor cycles to dopant precursor cycle), such as near a Si surface and the density of dopant at the top surface away from the substrate may be low (higher ratio of silicon precursor cycles to dopant precursor cycles). In other embodiments a high density of dopant may be provided at the top surface with a lower density near the substrate surface.
In some embodiments, an arsenosilicate glass layer is formed by providing a dopant precursor cycle at certain intervals in a silicon oxide deposition process. The interval may be based, for example, on cycle number or thickness. For example, one or more dopant precursor deposition cycles may be provided after each set of a predetermined number of silicon precursor deposition cycles, such as after every 10, 20, 50, 100, 200, 500 etc. cycles. In some embodiments, undoped silicon oxide deposition cycles may be repeated until a silicon oxide layer of a predetermined thickness is reached, at which point one or more dopant precursor cycles are then carried out. This process is repeated such that dopant is incorporated in the film at specific thickness intervals. For example, one or more dopant precursor cycles may be provided after each 5 nm of undoped SiO2 that is deposited. The process is then repeated until an arsenosilicate glass thin film of a desired thickness and composition has been deposited.
In some embodiments in an ALD process for producing arsenosilicate glass films, one or more “dopant oxide” deposition cycles are provided along with undoped silicon oxide deposition cycles. The process may also include one or more arsenosilicate glass deposition cycles.
In the “dopant oxide” deposition cycles, the silicon precursor is omitted from the arsenosilicate glass deposition cycles described above. Thus, the substrate is exposed to alternating and sequential pulses of dopant precursor and an oxidant, such as oxygen plasma. Other reactive oxygen sources may be used in some embodiments. In some embodiments, an arsenosilicate glass film is provided by conducting multiple dopant oxide deposition cycles and multiple silicon oxide deposition cycles. The ratio of dopant oxide cycles to silicon precursor cycles may be selected to control the dopant concentration in the ultimate arsenosilicate glass film. For example, for a low dopant density, the ratio of dopant oxide cycles to silicon precursor cycles may be on the order of 1:10. In other embodiments a high dopant density is achieved by increasing the ratio of dopant oxide cycles to silicon precursor cycles to 1:1 or even higher, such as 1.5:1, 2:1, 2.5:1, 3:1, 4:1 etc. For example, for a high dopant density, such as a high B density, the ratio of dopant oxide cycles to silicon precursor cycles may be on the order of 6:1, or even 10:1.
The density can be varied across the thickness of the film by changing the ratio of dopant oxide cycles to silicon oxide cycles during the deposition process. For example, a high density of dopant may be provided near the substrate surface by using a lower ratio of silicon oxide cycles to dopant oxide cycles and the density of dopant at the top surface may be lower by providing a higher ratio of silicon oxide cycles to dopant oxide cycles.
In some embodiments, an in-situ plasma pre-treatment of the substrate is conducted before SSD layer deposition to enhance doping efficiency into the Si fin. For example, H2 plasma pre-treatment can provide some tuning space for FinFET device design. The pre-treatment is not limited only H2 plasma. In some embodiments, the pre-treatment plasma may be selected from Ar, He, H2, fluorine-containing gas, and their mixed gas plasma.
In some embodiments, the ALD cycle disclosed in U.S. Patent Application Publication No. 2013/0115763, the disclosure of which is incorporated by reference in its entirety, can be employed for the ASG film (referred to also as “dopant layer”).
In some embodiments, the dopant layer is treated with a treating gas under conditions shown in Table 2 below.
Although the surface treatment is continuously conducted after completion of the ALD cycle, the surface treatment is not conducted as a part of the ASG film formation, but is a discrete step which is distinguished from the ASG film formation, i.e., the surface treatment is initiated after the ASG film formation is completely finished. For example, the surface treatment is not any part of ALD cycles for the ASG film and is initiated after purging upon completion of the ALD cycles (which purging is conducted using, e.g., a noble gas as such as Ar at a flow rate of 950 to 2,000 sccm for 3 to 60 seconds to remove O2 used in the ASG film formation prior to feeding SiH4 used in the surface treatment). Further, although the SiN cap formation is continuously conducted after completion of the surface treatment, the surface treatment is not conducted as a part of the SiN cap formation, i.e., the surface treatment is not initiated as a start-up step of the SiN cap formation although the SiN cap formation is continuously conducted upon the surface treatment (without any intervening step including purging). For example, the surface treatment is not any part of ALD cycles for the SiN cap. However, in some embodiments, gases which are the same as those used in the ALD cycles for the SiN cap can be used for the surface treatment. Further, in some embodiments, the flow rates of these gases in the surface treatment can be the same as those for the ALD cycles for the SiN cap. In some embodiments, continuingly fed gas such as dilution gas in the surface treatment can be continuously fed to the reaction space for the ALD cycles for the SiN cap after completion of the surface treatment without interruption. Alternatively, in some embodiments, at least some conditions for the surface treatment can be different from those for the ALD cycles for the SiN cap.
By avoiding exposure of the surface of the dopant layer to air or other oxygen-containing atmosphere, and by exposing the surface to a Si/N/H gas (i.e., a gas constituted by Si, N, and H), when the surface is covered with a cap layer, loss of dopant from the dopant layer can effectively be inhibited. Since the gases are not excited, the gases are adsorbed on the surface in a manner of chemisorption, typically, no film is formed on the surface of the dopant layer, but a layer similar to an atomic layer may be formed on the surface. The ratio of Si/N/H (i.e., the ratio of Si-containing gas/N-containing gas/H-containing gas) may be in a range of 2/(5-20)/(3-10) (Si<H<N), typically 2/10/5. Additionally, if the duration of the surface treatment is shorter than 3 seconds, whereas if the duration of the surface treatment is longer than 20 seconds.
Upon the surface treatment of the surface of the dopant layer, a SiN cap layer is continuously formed without being exposed to air or other oxygen-containing atmosphere. In some embodiments, the SiN cap layer may be formed by cyclic CVD or PEALD, one cycle of which cyclic CVD is conducted under conditions shown in Table 3 below. In cyclic CVD, a precursor for a SiN cap layer is typically pulsed while other gases and RF power are continuously charged; however, in place of or in addition to the precursor flow, RF power and any of the other gases can be pulsed as long as plasma reaction can occur in the reaction space, rather than on the substrate surface as in ALD. In some embodiments, the pressure of the reaction space is substantially constant while conducting cyclic CVD, wherein the pressure can be maintained by, e.g., switching precursor flow and inactive gas flow while continuously feeding the precursor and the inactive gas using a gas flow system illustrated in
In some embodiments, the SiN cap formation can be accomplished by PEALD under conditions similar to those indicated in Table 3 except that purging (e.g., 0.1 to 10.0 seconds, preferably 0.3 to 5 seconds) is conducted after the silicon precursor pulse, RF power is pulsed (e.g., 0.1 to 10 seconds, preferably 0.5 to 5 seconds), and after the RF power pulse, purging is conducted (e.g., 0.1 to 10 seconds, preferably 0.1 to 4 seconds).
In some embodiments, the gases and their flow rates used for the SiN cap formation are identical to those used for the surface treatment, and the SiN cap formation can be continuously conducted upon completion of the surface treatment. In some embodiments, Ar is used as a purge gas and continuously flows through its supply line, thereby flowing into the reaction space when the silicon precursor is not fed to the reaction space or flowing into a vent line when the silicon precursor is fed to the reaction space by valve switching. In some embodiments, the purge gas is Ar at a flow rate of about 950 sccm to about 2,000 sccm.
In some embodiments, the cap layer is directly over and contacting the dopant layer which has been treated with a treating gas. The cap layer is constituted by SiN. Since the surface of the dopant layer is covered with the SiN cap layer without being exposed to air, the SiN cap layer can effectively maintain As concentration in the dopant layer even if the thickness of the SiN cap layer is small such as less than 2 nm in some embodiments.
In some embodiments, the ALD cycle disclosed in U.S. Patent Application Publication No. 2013/0115763, the disclosure of which is incorporated by reference in its entirety, can be employed for the cap layer.
In some embodiments, after depositing the cap layer, the substrate is subjected to annealing to diffuse As into substrate. In some embodiments, the annealing may be conducted under conditions shown in Table 4 below.
The embodiments will be explained with respect to preferred embodiments. However, the present invention is not limited to the preferred embodiments.
In some embodiments, in the apparatus depicted in
In some embodiments, the surface treatment can be continuously conducted in a chamber different from the chamber used for the deposition of ASG film using a cluster apparatus (a substrate is transferred between chambers via a wafer-handling chamber without being exposed to air.
A skilled artisan will appreciate that the apparatus includes one or more controller(s) (not shown) programmed or otherwise configured to cause the deposition and reactor cleaning processes described elsewhere herein to be conducted. The controller(s) are communicated with the various power sources, heating systems, pumps, robotics and gas flow controllers or valves of the reactor, as will be appreciated by the skilled artisan.
The present invention is further explained with reference to working examples below. However, the examples are not intended to limit the present invention. In the examples where conditions and/or structures are not specified, the skilled artisan in the art can readily provide such conditions and/or structures, in view of the present disclosure, as a matter of routine experimentation. Also, the numbers applied in the specific examples can be modified by a range of at least ±50% in some embodiments, and the numbers are approximate.
An arsenosilicate glass (ASG) film was formed on a Si substrate (Φ300 mm) by PEALD, one cycle of which was conducted under the conditions shown in Table 5 below using the PEALD apparatus illustrated in
The dopant layer was treated in situ with a treating gas under conditions shown in Table 6 below in the same apparatus.
Thereafter, a SiN cap layer was formed in situ by cyclic CVD, one cycle of which was conducted under conditions shown in Table 7 below in the same apparatus (the gases and their flow rates were substantially the same as those for the surface treatment).
After depositing the cap layer, the substrate was subjected to annealing to diffuse As into Si substrate under conditions shown in Table 8 below.
As comparative examples, the following structures were produced:
Upon the annealing, the obtained films were analyzed in terms of sheet resistance (Rs) and junction depth (Xj). The results are shown in Table 10 below. The results are also shown in
As shown in Table 10 and
It will be understood by those of skill in the art that numerous and various modifications can be made without departing from the spirit of the present invention. Therefore, it should be clearly understood that the forms of the present invention are illustrative only and are not intended to limit the scope of the present invention.
Number | Name | Date | Kind |
---|---|---|---|
D56051 | Cohn | Aug 1920 | S |
2161626 | Loughner et al. | Jun 1939 | A |
2745640 | Cushman | May 1956 | A |
2990045 | Root | Sep 1959 | A |
3089507 | Drake et al. | May 1963 | A |
3094396 | Sylvester et al. | Jun 1963 | A |
3232437 | Hultgren | Feb 1966 | A |
3833492 | Bollyky | Sep 1974 | A |
3854443 | Baerg | Dec 1974 | A |
3862397 | Anderson et al. | Jan 1975 | A |
3887790 | Ferguson | Jun 1975 | A |
4054071 | Patejak | Oct 1977 | A |
4058430 | Suntola et al. | Nov 1977 | A |
4134425 | Gussefeld et al. | Jan 1979 | A |
4145699 | Hu et al. | Mar 1979 | A |
4176630 | Elmer | Dec 1979 | A |
4181330 | Kojima | Jan 1980 | A |
4194536 | Stine et al. | Mar 1980 | A |
4322592 | Martin | Mar 1982 | A |
4389973 | Suntola et al. | Jun 1983 | A |
4393013 | McMenamin | Jul 1983 | A |
4401507 | Engle | Aug 1983 | A |
4414492 | Hanlet | Nov 1983 | A |
4436674 | McMenamin | Mar 1984 | A |
4479831 | Sandow et al. | Oct 1984 | A |
4499354 | Hill et al. | Feb 1985 | A |
4512113 | Budinger | Apr 1985 | A |
4570328 | Price et al. | Feb 1986 | A |
4579623 | Suzuki et al. | Apr 1986 | A |
D288556 | Wallgren | Mar 1987 | S |
4653541 | Oehlschlaeger et al. | Mar 1987 | A |
4654226 | Jackson et al. | Mar 1987 | A |
4681134 | Paris | Jul 1987 | A |
4718637 | Contin | Jan 1988 | A |
4722298 | Rubin et al. | Feb 1988 | A |
4735259 | Vincent | Apr 1988 | A |
4753192 | Goldsmith et al. | Jun 1988 | A |
4756794 | Yoder | Jul 1988 | A |
4780169 | Stark et al. | Oct 1988 | A |
4789294 | Sato et al. | Dec 1988 | A |
4821674 | deBoer et al. | Apr 1989 | A |
4827430 | Aid et al. | May 1989 | A |
4837185 | Yau et al. | Jun 1989 | A |
4854263 | Chang et al. | Aug 1989 | A |
4857137 | Tashiro et al. | Aug 1989 | A |
4857504 | Hermann et al. | Aug 1989 | A |
4882199 | Sadoway et al. | Nov 1989 | A |
4976996 | Monkowski et al. | Dec 1990 | A |
4978567 | Miller | Dec 1990 | A |
4984904 | Nakano et al. | Jan 1991 | A |
4985114 | Okudaira | Jan 1991 | A |
4986215 | Yamada | Jan 1991 | A |
4987856 | Hey | Jan 1991 | A |
4991614 | Hammel | Feb 1991 | A |
5013691 | Lory et al. | May 1991 | A |
5027746 | Frijlink | Jul 1991 | A |
5028366 | Harakal et al. | Jul 1991 | A |
5060322 | Delepine | Oct 1991 | A |
5062386 | Christensen | Nov 1991 | A |
5065698 | Koike | Nov 1991 | A |
5074017 | Toya et al. | Dec 1991 | A |
5098638 | Sawada | Mar 1992 | A |
5104514 | Quartarone | Apr 1992 | A |
5116018 | Friemoth et al. | May 1992 | A |
D327534 | Manville | Jun 1992 | S |
5119760 | McMillan et al. | Jun 1992 | A |
5167716 | Boitnott et al. | Dec 1992 | A |
5178682 | Tsukamoto et al. | Jan 1993 | A |
5183511 | Yamazaki et al. | Feb 1993 | A |
5192717 | Kawakami | Mar 1993 | A |
5194401 | Adams et al. | Mar 1993 | A |
5199603 | Prescott | Apr 1993 | A |
5221556 | Hawkins et al. | Jun 1993 | A |
5242539 | Kumihashi et al. | Sep 1993 | A |
5243195 | Nishi | Sep 1993 | A |
5246500 | Samata et al. | Sep 1993 | A |
5271967 | Kramer et al. | Dec 1993 | A |
5288684 | Yamazaki et al. | Feb 1994 | A |
5306946 | Yamamoto | Apr 1994 | A |
5315092 | Takahashi et al. | May 1994 | A |
5326427 | Jerbic | Jul 1994 | A |
5336327 | Lee | Aug 1994 | A |
5354580 | Goela et al. | Oct 1994 | A |
5356478 | Chen et al. | Oct 1994 | A |
5360269 | Ogawa et al. | Nov 1994 | A |
5380367 | Bertone | Jan 1995 | A |
5382311 | Ishikawa et al. | Jan 1995 | A |
5404082 | Hernandez et al. | Apr 1995 | A |
5413813 | Cruse et al. | May 1995 | A |
5415753 | Hurwitt et al. | May 1995 | A |
5421893 | Perlov | Jun 1995 | A |
5422139 | Fischer | Jun 1995 | A |
5430011 | Tanaka et al. | Jul 1995 | A |
5494494 | Mizuno et al. | Feb 1996 | A |
5496408 | Motoda et al. | Mar 1996 | A |
5504042 | Cho et al. | Apr 1996 | A |
5518549 | Hellwig | May 1996 | A |
5527417 | Iida et al. | Jun 1996 | A |
5531835 | Fodor et al. | Jul 1996 | A |
5574247 | Nishitani et al. | Nov 1996 | A |
5577331 | Suzuki | Nov 1996 | A |
5589002 | Su | Dec 1996 | A |
5589110 | Motoda et al. | Dec 1996 | A |
5595606 | Fujikawa et al. | Jan 1997 | A |
5601641 | Stephens | Feb 1997 | A |
5604410 | Vollkommer et al. | Feb 1997 | A |
5616947 | Tamura | Apr 1997 | A |
5621982 | Yamashita et al. | Apr 1997 | A |
5632919 | MacCracken et al. | May 1997 | A |
D380527 | Velez | Jul 1997 | S |
5679215 | Barnes et al. | Oct 1997 | A |
5681779 | Pasch et al. | Oct 1997 | A |
5683517 | Shan | Nov 1997 | A |
5695567 | Kordina | Dec 1997 | A |
5718574 | Shimazu | Feb 1998 | A |
5724748 | Brooks | Mar 1998 | A |
5728223 | Murakami et al. | Mar 1998 | A |
5730801 | Tepman et al. | Mar 1998 | A |
5732744 | Barr et al. | Mar 1998 | A |
5736314 | Hayes et al. | Apr 1998 | A |
5777838 | Tamagawa et al. | Jul 1998 | A |
5781693 | Ballance et al. | Jul 1998 | A |
5796074 | Edelstein et al. | Aug 1998 | A |
5801104 | Schuegraf et al. | Sep 1998 | A |
5819434 | Herchen et al. | Oct 1998 | A |
5827757 | Robinson, Jr. et al. | Oct 1998 | A |
5836483 | Disel | Nov 1998 | A |
5837320 | Hampden-Smith et al. | Nov 1998 | A |
5852879 | Schumaier | Dec 1998 | A |
5853484 | Jeong | Dec 1998 | A |
5855680 | Soininen et al. | Jan 1999 | A |
5855681 | Maydan et al. | Jan 1999 | A |
5873942 | Park | Feb 1999 | A |
5877095 | Tamura et al. | Mar 1999 | A |
D409894 | McClurg | May 1999 | S |
5908672 | Ryu | Jun 1999 | A |
5916365 | Sherman | Jun 1999 | A |
5920798 | Higuchi et al. | Jul 1999 | A |
5968275 | Lee et al. | Oct 1999 | A |
5975492 | Brenes | Nov 1999 | A |
5979506 | Aarseth | Nov 1999 | A |
5997588 | Goodwin | Dec 1999 | A |
5997768 | Scully | Dec 1999 | A |
D419652 | Hall et al. | Jan 2000 | S |
6013553 | Wallace | Jan 2000 | A |
6015465 | Kholodenko et al. | Jan 2000 | A |
6017779 | Miyasaka | Jan 2000 | A |
6024799 | Chen et al. | Feb 2000 | A |
6035101 | Sajoto et al. | Mar 2000 | A |
6042652 | Hyun | Mar 2000 | A |
6044860 | Neu | Apr 2000 | A |
6050506 | Guo et al. | Apr 2000 | A |
6060691 | Minami et al. | May 2000 | A |
6074443 | Venkatesh | Jun 2000 | A |
6083321 | Lei et al. | Jul 2000 | A |
6086677 | Umotoy et al. | Jul 2000 | A |
6099302 | Hong et al. | Aug 2000 | A |
6122036 | Yamasaki et al. | Sep 2000 | A |
6124600 | Moroishi et al. | Sep 2000 | A |
6125789 | Gupta et al. | Oct 2000 | A |
6129044 | Zhao et al. | Oct 2000 | A |
6134807 | Komino | Oct 2000 | A |
6137240 | Bogdan et al. | Oct 2000 | A |
6140252 | Cho et al. | Oct 2000 | A |
6148761 | Majewski et al. | Nov 2000 | A |
6160244 | Ohashi | Dec 2000 | A |
6161500 | Kopacz et al. | Dec 2000 | A |
6162323 | Koshimizu et al. | Dec 2000 | A |
6180979 | Hofmann et al. | Jan 2001 | B1 |
6187691 | Fukuda | Feb 2001 | B1 |
6190634 | Lieber et al. | Feb 2001 | B1 |
6194037 | Terasaki et al. | Feb 2001 | B1 |
6201999 | Jevtic | Mar 2001 | B1 |
6207932 | Yoo | Mar 2001 | B1 |
6212789 | Kato | Apr 2001 | B1 |
6218288 | Li et al. | Apr 2001 | B1 |
6250250 | Maishev et al. | Jun 2001 | B1 |
6271148 | Kao | Aug 2001 | B1 |
6274878 | Li et al. | Aug 2001 | B1 |
6281098 | Wang | Aug 2001 | B1 |
6287965 | Kang et al. | Sep 2001 | B1 |
D449873 | Bronson | Oct 2001 | S |
6296909 | Spitsberg | Oct 2001 | B1 |
6299133 | Waragai et al. | Oct 2001 | B2 |
6302964 | Umotoy et al. | Oct 2001 | B1 |
6303523 | Cheung | Oct 2001 | B2 |
6305898 | Yamagishi et al. | Oct 2001 | B1 |
6312525 | Bright et al. | Nov 2001 | B1 |
6315512 | Tabrizi et al. | Nov 2001 | B1 |
D451893 | Robson | Dec 2001 | S |
D452220 | Robson | Dec 2001 | S |
6325858 | Wengert | Dec 2001 | B1 |
6326597 | Lubomirsky et al. | Dec 2001 | B1 |
6329297 | Balish | Dec 2001 | B1 |
6342427 | Choi et al. | Jan 2002 | B1 |
6347636 | Xia | Feb 2002 | B1 |
6352945 | Matsuki | Mar 2002 | B1 |
6367410 | Leahey et al. | Apr 2002 | B1 |
6368987 | Kopacz et al. | Apr 2002 | B1 |
6370796 | Zucker | Apr 2002 | B1 |
6372583 | Tyagi | Apr 2002 | B1 |
6374831 | Chandran | Apr 2002 | B1 |
6375312 | Ikeda et al. | Apr 2002 | B1 |
D457609 | Piano | May 2002 | S |
6383566 | Zagdoun | May 2002 | B1 |
6383955 | Matsuki | May 2002 | B1 |
6387207 | Janakiraman | May 2002 | B1 |
6391803 | Kim et al. | May 2002 | B1 |
6398184 | Sowada et al. | Jun 2002 | B1 |
6410459 | Blalock et al. | Jun 2002 | B2 |
6413321 | Kim et al. | Jul 2002 | B1 |
6413583 | Moghadam et al. | Jul 2002 | B1 |
6420279 | Ono et al. | Jul 2002 | B1 |
D461233 | Whalen | Aug 2002 | S |
D461882 | Piano | Aug 2002 | S |
6435798 | Satoh | Aug 2002 | B1 |
6436819 | Zhang | Aug 2002 | B1 |
6437444 | Andideh | Aug 2002 | B2 |
6445574 | Saw et al. | Sep 2002 | B1 |
6446573 | Hirayama et al. | Sep 2002 | B2 |
6450757 | Saeki | Sep 2002 | B1 |
6454860 | Metzner et al. | Sep 2002 | B2 |
6455445 | Matsuki | Sep 2002 | B2 |
6461435 | Littau et al. | Oct 2002 | B1 |
6468924 | Lee | Oct 2002 | B2 |
6472266 | Yu et al. | Oct 2002 | B1 |
6475276 | Elers et al. | Nov 2002 | B1 |
6475930 | Junker et al. | Nov 2002 | B1 |
6478872 | Chae et al. | Nov 2002 | B1 |
6482331 | Lu et al. | Nov 2002 | B2 |
6482663 | Backlund | Nov 2002 | B1 |
6483989 | Okada et al. | Nov 2002 | B1 |
6494065 | Babbitt | Dec 2002 | B2 |
6499533 | Yamada | Dec 2002 | B2 |
6503562 | Saito et al. | Jan 2003 | B1 |
6503826 | Oda | Jan 2003 | B1 |
6511539 | Raaijmakers | Jan 2003 | B1 |
6521295 | Remington | Feb 2003 | B1 |
6521547 | Chang et al. | Feb 2003 | B1 |
6528430 | Kwan | Mar 2003 | B2 |
6528767 | Bagley et al. | Mar 2003 | B2 |
6531193 | Fonash et al. | Mar 2003 | B2 |
6531412 | Conti et al. | Mar 2003 | B2 |
6534395 | Werkhoven et al. | Mar 2003 | B2 |
6558755 | Berry et al. | May 2003 | B2 |
6569239 | Arai et al. | May 2003 | B2 |
6573030 | Fairbairn et al. | Jun 2003 | B1 |
6576062 | Matsuse | Jun 2003 | B2 |
6576064 | Griffiths et al. | Jun 2003 | B2 |
6576300 | Berry et al. | Jun 2003 | B1 |
6579833 | McNallan et al. | Jun 2003 | B1 |
6583048 | Vincent et al. | Jun 2003 | B1 |
6590251 | Kang et al. | Jul 2003 | B2 |
6594550 | Okrah | Jul 2003 | B1 |
6598559 | Vellore et al. | Jul 2003 | B1 |
6627503 | Ma et al. | Sep 2003 | B2 |
6632478 | Gaillard et al. | Oct 2003 | B2 |
6633364 | Hayashi | Oct 2003 | B2 |
6635117 | Kinnard et al. | Oct 2003 | B1 |
6638839 | Deng et al. | Oct 2003 | B2 |
6645304 | Yamaguchi | Nov 2003 | B2 |
6648974 | Ogliari et al. | Nov 2003 | B1 |
6649921 | Cekic et al. | Nov 2003 | B1 |
6652924 | Sherman | Nov 2003 | B2 |
6673196 | Oyabu | Jan 2004 | B1 |
6682973 | Paton et al. | Jan 2004 | B1 |
D486891 | Cronce | Feb 2004 | S |
6688784 | Templeton | Feb 2004 | B1 |
6689220 | Nguyen | Feb 2004 | B1 |
6692575 | Omstead et al. | Feb 2004 | B1 |
6692576 | Halpin et al. | Feb 2004 | B2 |
6699003 | Saeki | Mar 2004 | B2 |
6709989 | Ramdani et al. | Mar 2004 | B2 |
6710364 | Guldi et al. | Mar 2004 | B2 |
6713824 | Mikata | Mar 2004 | B1 |
6716571 | Gabriel | Apr 2004 | B2 |
6723642 | Lim et al. | Apr 2004 | B1 |
6730614 | Lim et al. | May 2004 | B1 |
6734090 | Agarwala et al. | May 2004 | B2 |
6740853 | Johnson et al. | May 2004 | B1 |
6743475 | Skarp et al. | Jun 2004 | B2 |
6743738 | Todd et al. | Jun 2004 | B2 |
6753507 | Fure et al. | Jun 2004 | B2 |
6756318 | Nguyen et al. | Jun 2004 | B2 |
6759098 | Han | Jul 2004 | B2 |
6760981 | Leap | Jul 2004 | B2 |
6784108 | Donohoe et al. | Aug 2004 | B1 |
D497977 | Engelbrektsson | Nov 2004 | S |
6815350 | Kim et al. | Nov 2004 | B2 |
6820570 | Kilpela et al. | Nov 2004 | B2 |
6821910 | Adomaitis et al. | Nov 2004 | B2 |
6824665 | Shelnut et al. | Nov 2004 | B2 |
6825134 | Law et al. | Nov 2004 | B2 |
6846515 | Vrtis | Jan 2005 | B2 |
6847014 | Benjamin et al. | Jan 2005 | B1 |
6858524 | Haukka et al. | Feb 2005 | B2 |
6858547 | Metzner | Feb 2005 | B2 |
6863019 | Shamouilian et al. | Mar 2005 | B2 |
6864041 | Brown | Mar 2005 | B2 |
6872258 | Park et al. | Mar 2005 | B2 |
6872259 | Strang | Mar 2005 | B2 |
6874247 | Hsu | Apr 2005 | B1 |
6874480 | Ismailov | Apr 2005 | B1 |
6875677 | Conley, Jr. et al. | Apr 2005 | B1 |
6876017 | Goodner | Apr 2005 | B2 |
6884066 | Nguyen et al. | Apr 2005 | B2 |
6884319 | Kim | Apr 2005 | B2 |
6889864 | Lindfors et al. | May 2005 | B2 |
6895158 | Aylward et al. | May 2005 | B2 |
6899507 | Yamagishi et al. | May 2005 | B2 |
6909839 | Wang et al. | Jun 2005 | B2 |
6911092 | Sneh | Jun 2005 | B2 |
6913796 | Albano et al. | Jul 2005 | B2 |
6930059 | Conley, Jr. et al. | Aug 2005 | B2 |
6935269 | Lee et al. | Aug 2005 | B2 |
6939817 | Sandhu et al. | Sep 2005 | B2 |
6951587 | Narushima | Oct 2005 | B1 |
6953609 | Carollo | Oct 2005 | B2 |
6955836 | Kumagai et al. | Oct 2005 | B2 |
6972478 | Waite et al. | Dec 2005 | B1 |
6974781 | Timmermans et al. | Dec 2005 | B2 |
6976822 | Woodruff | Dec 2005 | B2 |
6984595 | Yamazaki | Jan 2006 | B1 |
6990430 | Hosek | Jan 2006 | B2 |
7021881 | Yamagishi | Apr 2006 | B2 |
7045430 | Ahn et al. | May 2006 | B2 |
7049247 | Gates et al. | May 2006 | B2 |
7053009 | Conley, Jr. et al. | May 2006 | B2 |
7055875 | Bonora | Jun 2006 | B2 |
7071051 | Jeon et al. | Jul 2006 | B1 |
7084079 | Conti et al. | Aug 2006 | B2 |
7088003 | Gates et al. | Aug 2006 | B2 |
7092287 | Beulens et al. | Aug 2006 | B2 |
7098149 | Lukas | Aug 2006 | B2 |
7109098 | Ramaswamy et al. | Sep 2006 | B1 |
7115838 | Kurara et al. | Oct 2006 | B2 |
7122085 | Shero et al. | Oct 2006 | B2 |
7122222 | Xiao et al. | Oct 2006 | B2 |
7129165 | Basol et al. | Oct 2006 | B2 |
7132360 | Schaeffer et al. | Nov 2006 | B2 |
7135421 | Ahn et al. | Nov 2006 | B2 |
7143897 | Guzman et al. | Dec 2006 | B1 |
7147766 | Uzoh et al. | Dec 2006 | B2 |
7153542 | Nguyen et al. | Dec 2006 | B2 |
7163721 | Zhang et al. | Jan 2007 | B2 |
7163900 | Weber | Jan 2007 | B2 |
7172497 | Basol et al. | Feb 2007 | B2 |
7192824 | Ahn et al. | Mar 2007 | B2 |
7192892 | Ahn et al. | Mar 2007 | B2 |
7195693 | Cowans | Mar 2007 | B2 |
7201943 | Park et al. | Apr 2007 | B2 |
7204887 | Kawamura et al. | Apr 2007 | B2 |
7205246 | MacNeil et al. | Apr 2007 | B2 |
7205247 | Lee et al. | Apr 2007 | B2 |
7207763 | Lee | Apr 2007 | B2 |
7208389 | Tipton et al. | Apr 2007 | B1 |
7211524 | Ryu et al. | May 2007 | B2 |
7234476 | Arai | Jun 2007 | B2 |
7235137 | Kitayama et al. | Jun 2007 | B2 |
7235482 | Wu | Jun 2007 | B2 |
7235501 | Ahn et al. | Jun 2007 | B2 |
7238596 | Kouvetakis et al. | Jul 2007 | B2 |
7265061 | Cho et al. | Sep 2007 | B1 |
D553104 | Oohashi et al. | Oct 2007 | S |
7290813 | Bonora | Nov 2007 | B2 |
7294581 | Iyer et al. | Nov 2007 | B2 |
7297641 | Todd et al. | Nov 2007 | B2 |
7298009 | Yan et al. | Nov 2007 | B2 |
D557226 | Uchino et al. | Dec 2007 | S |
7307178 | Kiyomori et al. | Dec 2007 | B2 |
7312148 | Ramaswamy et al. | Dec 2007 | B2 |
7312162 | Ramaswamy et al. | Dec 2007 | B2 |
7312494 | Ahn et al. | Dec 2007 | B2 |
7323401 | Ramaswamy et al. | Jan 2008 | B2 |
7326657 | Xia et al. | Feb 2008 | B2 |
7327948 | Shrinivasan | Feb 2008 | B1 |
7329947 | Adachi et al. | Feb 2008 | B2 |
7335611 | Ramaswamy et al. | Feb 2008 | B2 |
7354847 | Chan et al. | Apr 2008 | B2 |
7357138 | Ji et al. | Apr 2008 | B2 |
7381644 | Subramonium et al. | Jun 2008 | B1 |
7393418 | Yokogawa | Jul 2008 | B2 |
7393736 | Ahn et al. | Jul 2008 | B2 |
7393765 | Hanawa et al. | Jul 2008 | B2 |
7396491 | Marking et al. | Jul 2008 | B2 |
7399388 | Moghadam et al. | Jul 2008 | B2 |
7402534 | Mahajani | Jul 2008 | B2 |
7405166 | Liang et al. | Jul 2008 | B2 |
7405454 | Ahn et al. | Jul 2008 | B2 |
D575713 | Ratcliffe | Aug 2008 | S |
7411352 | Madocks | Aug 2008 | B2 |
7414281 | Fastow | Aug 2008 | B1 |
7416989 | Liu et al. | Aug 2008 | B1 |
7422653 | Blahnik et al. | Sep 2008 | B2 |
7422775 | Ramaswamy et al. | Sep 2008 | B2 |
7429532 | Ramaswamy et al. | Sep 2008 | B2 |
7431966 | Derderian et al. | Oct 2008 | B2 |
7437060 | Wang et al. | Oct 2008 | B2 |
7442275 | Cowans | Oct 2008 | B2 |
7476291 | Wang et al. | Jan 2009 | B2 |
7479198 | Guffrey | Jan 2009 | B2 |
D585968 | Elkins et al. | Feb 2009 | S |
7489389 | Shibazaki | Feb 2009 | B2 |
7494882 | Vitale | Feb 2009 | B2 |
7498242 | Kumar et al. | Mar 2009 | B2 |
7501292 | Matsushita et al. | Mar 2009 | B2 |
7503980 | Kida et al. | Mar 2009 | B2 |
D590933 | Vansell et al. | Apr 2009 | S |
7514375 | Shanker et al. | Apr 2009 | B1 |
D593969 | Li | Jun 2009 | S |
7541297 | Mallick et al. | Jun 2009 | B2 |
7547363 | Tomiyasu et al. | Jun 2009 | B2 |
7550396 | Frohberg et al. | Jun 2009 | B2 |
7566891 | Rocha-Alvarez et al. | Jul 2009 | B2 |
7575968 | Sadaka et al. | Aug 2009 | B2 |
7579785 | Shinmen et al. | Aug 2009 | B2 |
7582555 | Lang | Sep 2009 | B1 |
7589003 | Kouvetakis et al. | Sep 2009 | B2 |
7589029 | Derderian et al. | Sep 2009 | B2 |
D602575 | Breda | Oct 2009 | S |
7598513 | Kouvetakis et al. | Oct 2009 | B2 |
7601223 | Lindfors et al. | Oct 2009 | B2 |
7601225 | Tuominen et al. | Oct 2009 | B2 |
7611751 | Elers | Nov 2009 | B2 |
7611980 | Wells et al. | Nov 2009 | B2 |
7618226 | Takizawa | Nov 2009 | B2 |
D606952 | Lee | Dec 2009 | S |
7629277 | Ghatnagar | Dec 2009 | B2 |
7632549 | Goundar | Dec 2009 | B2 |
7640142 | Tachikawa et al. | Dec 2009 | B2 |
7651583 | Kent et al. | Jan 2010 | B2 |
7651961 | Clark | Jan 2010 | B2 |
D609652 | Nagasaka | Feb 2010 | S |
D609655 | Sugimoto | Feb 2010 | S |
7678197 | Maki | Mar 2010 | B2 |
7678715 | Mungekar et al. | Mar 2010 | B2 |
7682657 | Sherman | Mar 2010 | B2 |
D613829 | Griffin et al. | Apr 2010 | S |
D614153 | Fondurulia et al. | Apr 2010 | S |
D614267 | Breda | Apr 2010 | S |
D614268 | Breda | Apr 2010 | S |
D614593 | Lee | Apr 2010 | S |
7690881 | Yamagishi | Apr 2010 | B2 |
7691205 | Ikedo | Apr 2010 | B2 |
7713874 | Milligan | May 2010 | B2 |
7720560 | Menser et al. | May 2010 | B2 |
7723648 | Tsukamoto et al. | May 2010 | B2 |
7727864 | Elers | Jun 2010 | B2 |
7732343 | Niroomand et al. | Jun 2010 | B2 |
7740705 | Li | Jun 2010 | B2 |
7745346 | Hausmann et al. | Jun 2010 | B2 |
7748760 | Kushida | Jul 2010 | B2 |
7754621 | Putkonen | Jul 2010 | B2 |
7763869 | Matsushita et al. | Jul 2010 | B2 |
7767262 | Clark | Aug 2010 | B2 |
7771796 | Kohno et al. | Aug 2010 | B2 |
7780440 | Shibagaki et al. | Aug 2010 | B2 |
7789965 | Matsushita et al. | Sep 2010 | B2 |
7790633 | Tarafdar et al. | Sep 2010 | B1 |
7803722 | Liang | Sep 2010 | B2 |
7807578 | Bencher et al. | Oct 2010 | B2 |
7816278 | Reid et al. | Oct 2010 | B2 |
7824492 | Tois et al. | Nov 2010 | B2 |
7825040 | Fukazawa et al. | Nov 2010 | B1 |
7833353 | Furukawahara et al. | Nov 2010 | B2 |
7838084 | Derderian et al. | Nov 2010 | B2 |
7842518 | Miyajima | Nov 2010 | B2 |
7842622 | Lee et al. | Nov 2010 | B1 |
D629874 | Hermans | Dec 2010 | S |
7851019 | Tuominen et al. | Dec 2010 | B2 |
7851232 | van Schravendijk et al. | Dec 2010 | B2 |
7865070 | Nakamura | Jan 2011 | B2 |
7884918 | Hattori | Feb 2011 | B2 |
7888233 | Gauri | Feb 2011 | B1 |
D634719 | Yasuda et al. | Mar 2011 | S |
7897215 | Fair et al. | Mar 2011 | B1 |
7902582 | Forbes et al. | Mar 2011 | B2 |
7910288 | Abatchev et al. | Mar 2011 | B2 |
7915139 | Lang | Mar 2011 | B1 |
7919416 | Lee et al. | Apr 2011 | B2 |
7925378 | Gilchrist et al. | Apr 2011 | B2 |
7935940 | Smargiassi | May 2011 | B1 |
7939447 | Bauer et al. | May 2011 | B2 |
7955516 | Chandrachood et al. | Jun 2011 | B2 |
7963736 | Takizawa et al. | Jun 2011 | B2 |
7972980 | Lee et al. | Jul 2011 | B2 |
7981751 | Zhu et al. | Jul 2011 | B2 |
D643055 | Takahashi | Aug 2011 | S |
7992318 | Kawaji | Aug 2011 | B2 |
7994721 | Espiau et al. | Aug 2011 | B2 |
7998875 | DeYoung | Aug 2011 | B2 |
8003174 | Fukazawa | Aug 2011 | B2 |
8004198 | Bakre et al. | Aug 2011 | B2 |
8020315 | Nishimura | Sep 2011 | B2 |
8030129 | Jeong | Oct 2011 | B2 |
8038835 | Hayashi et al. | Oct 2011 | B2 |
8041197 | Kasai et al. | Oct 2011 | B2 |
8041450 | Takizawa et al. | Oct 2011 | B2 |
8043972 | Liu et al. | Oct 2011 | B1 |
8055378 | Numakura | Nov 2011 | B2 |
8060252 | Gage et al. | Nov 2011 | B2 |
8071451 | Berry | Dec 2011 | B2 |
8071452 | Raisanen | Dec 2011 | B2 |
8072578 | Yasuda et al. | Dec 2011 | B2 |
8076230 | Wei | Dec 2011 | B2 |
8076237 | Uzoh | Dec 2011 | B2 |
8082946 | Laverdiere et al. | Dec 2011 | B2 |
D652896 | Grether | Jan 2012 | S |
8092604 | Tomiyasu et al. | Jan 2012 | B2 |
D653734 | Sisk | Feb 2012 | S |
D654884 | Honma | Feb 2012 | S |
D655055 | Toll | Feb 2012 | S |
8119466 | Avouris | Feb 2012 | B2 |
8137462 | Fondurulia et al. | Mar 2012 | B2 |
8137465 | Shrinivasan et al. | Mar 2012 | B1 |
8138676 | Mills | Mar 2012 | B2 |
8142862 | Lee et al. | Mar 2012 | B2 |
8143174 | Xia et al. | Mar 2012 | B2 |
8147242 | Shibagaki et al. | Apr 2012 | B2 |
8173554 | Lee et al. | May 2012 | B2 |
8187951 | Wang | May 2012 | B1 |
8192901 | Kageyama | Jun 2012 | B2 |
8196234 | Glunk | Jun 2012 | B2 |
8197915 | Oka et al. | Jun 2012 | B2 |
8216380 | White et al. | Jul 2012 | B2 |
8231799 | Bera et al. | Jul 2012 | B2 |
D665055 | Yanagisawa et al. | Aug 2012 | S |
8241991 | Hsieh et al. | Aug 2012 | B2 |
8242031 | Mallick et al. | Aug 2012 | B2 |
8252114 | Vukovic | Aug 2012 | B2 |
8252659 | Huyghebaert et al. | Aug 2012 | B2 |
8252691 | Beynet et al. | Aug 2012 | B2 |
8272516 | Salvador | Sep 2012 | B2 |
8278176 | Bauer et al. | Oct 2012 | B2 |
8282769 | Iizuka | Oct 2012 | B2 |
8287648 | Reed et al. | Oct 2012 | B2 |
8293016 | Bahng et al. | Oct 2012 | B2 |
8298951 | Nakano | Oct 2012 | B1 |
8307472 | Saxon et al. | Nov 2012 | B1 |
8309173 | Tuominen et al. | Nov 2012 | B2 |
8323413 | Son | Dec 2012 | B2 |
8329599 | Fukazawa et al. | Dec 2012 | B2 |
8334219 | Lee et al. | Dec 2012 | B2 |
D676943 | Kluss | Feb 2013 | S |
8367528 | Bauer et al. | Feb 2013 | B2 |
8372204 | Nakamura | Feb 2013 | B2 |
8393091 | Kawamoto | Mar 2013 | B2 |
8394466 | Hong et al. | Mar 2013 | B2 |
8415259 | Lee et al. | Apr 2013 | B2 |
8440259 | Chiang et al. | May 2013 | B2 |
8444120 | Gregg et al. | May 2013 | B2 |
8445075 | Xu et al. | May 2013 | B2 |
8465811 | Ueda | Jun 2013 | B2 |
8466411 | Arai | Jun 2013 | B2 |
8470187 | Ha | Jun 2013 | B2 |
8484846 | Dhindsa | Jul 2013 | B2 |
8492170 | Xie et al. | Jul 2013 | B2 |
8496756 | Cruse et al. | Jul 2013 | B2 |
8506713 | Takagi | Aug 2013 | B2 |
8535767 | Kimura | Sep 2013 | B1 |
D691974 | Osada et al. | Oct 2013 | S |
8551892 | Nakano | Oct 2013 | B2 |
8563443 | Fukazawa | Oct 2013 | B2 |
8569184 | Oka | Oct 2013 | B2 |
8591659 | Fang et al. | Nov 2013 | B1 |
8592005 | Ueda | Nov 2013 | B2 |
8608885 | Goto et al. | Dec 2013 | B2 |
8617411 | Singh | Dec 2013 | B2 |
8633115 | Chang et al. | Jan 2014 | B2 |
8647722 | Kobayashi et al. | Feb 2014 | B2 |
8664627 | Ishikawa et al. | Mar 2014 | B1 |
8667654 | Gros-Jean | Mar 2014 | B2 |
8668957 | Dussarrat et al. | Mar 2014 | B2 |
8669185 | Onizawa | Mar 2014 | B2 |
8683943 | Onodera et al. | Apr 2014 | B2 |
8711338 | Liu et al. | Apr 2014 | B2 |
D705745 | Kurs et al. | May 2014 | S |
8720965 | Hino et al. | May 2014 | B2 |
8722546 | Fukazawa et al. | May 2014 | B2 |
8726837 | Patalay et al. | May 2014 | B2 |
8728832 | Raisanen et al. | May 2014 | B2 |
8742668 | Nakano et al. | Jun 2014 | B2 |
8764085 | Urabe | Jul 2014 | B2 |
8784950 | Fukazawa et al. | Jul 2014 | B2 |
8784951 | Fukazawa et al. | Jul 2014 | B2 |
8785215 | Kobayashi et al. | Jul 2014 | B2 |
8790749 | Omori et al. | Jul 2014 | B2 |
8802201 | Raisanen et al. | Aug 2014 | B2 |
8820809 | Ando et al. | Sep 2014 | B2 |
8821640 | Cleary et al. | Sep 2014 | B2 |
8841182 | Chen et al. | Sep 2014 | B1 |
8845806 | Aida et al. | Sep 2014 | B2 |
D715410 | Lohmann | Oct 2014 | S |
8864202 | Schrameyer | Oct 2014 | B1 |
D716742 | Jang et al. | Nov 2014 | S |
8877655 | Shero et al. | Nov 2014 | B2 |
8883270 | Shero et al. | Nov 2014 | B2 |
8901016 | Ha et al. | Dec 2014 | B2 |
8911826 | Adachi et al. | Dec 2014 | B2 |
8912101 | Tsuji et al. | Dec 2014 | B2 |
D720838 | Yamagishi et al. | Jan 2015 | S |
8933375 | Dunn et al. | Jan 2015 | B2 |
8940646 | Chandrasekharan | Jan 2015 | B1 |
D723153 | Borkholder | Feb 2015 | S |
8946830 | Jung et al. | Feb 2015 | B2 |
8956983 | Swaminathan | Feb 2015 | B2 |
D724553 | Choi | Mar 2015 | S |
D724701 | Yamagishi et al. | Mar 2015 | S |
D725168 | Yamagishi | Mar 2015 | S |
8967608 | Mitsumori et al. | Mar 2015 | B2 |
8986456 | Fondurulia et al. | Mar 2015 | B2 |
8991887 | Shin et al. | Mar 2015 | B2 |
8993054 | Jung et al. | Mar 2015 | B2 |
D726365 | Weigensberg | Apr 2015 | S |
D726884 | Yamagishi et al. | Apr 2015 | S |
9005539 | Halpin et al. | Apr 2015 | B2 |
9017481 | Pettinger et al. | Apr 2015 | B1 |
9018093 | Tsuji et al. | Apr 2015 | B2 |
9018111 | Milligan et al. | Apr 2015 | B2 |
9021985 | Alokozai et al. | May 2015 | B2 |
9023737 | Beynet et al. | May 2015 | B2 |
9029253 | Milligan et al. | May 2015 | B2 |
9029272 | Nakano et al. | May 2015 | B1 |
D732145 | Yamagishi | Jun 2015 | S |
D732644 | Yamagishi et al. | Jun 2015 | S |
D733261 | Yamagishi et al. | Jun 2015 | S |
D733843 | Yamagishi et al. | Jul 2015 | S |
D734377 | Hirakida | Jul 2015 | S |
D735836 | Yamagishi | Aug 2015 | S |
9096931 | Yednak et al. | Aug 2015 | B2 |
9117657 | Nakano et al. | Aug 2015 | B2 |
9117866 | Marquardt et al. | Aug 2015 | B2 |
D739222 | Chadbourne | Sep 2015 | S |
9123510 | Nakano et al. | Sep 2015 | B2 |
9136108 | Matsushita et al. | Sep 2015 | B2 |
9142393 | Okabe et al. | Sep 2015 | B2 |
9169975 | Sarin et al. | Oct 2015 | B2 |
9171714 | Mori | Oct 2015 | B2 |
9171716 | Fukuda | Oct 2015 | B2 |
D743513 | Yamagishi | Nov 2015 | S |
9177784 | Raisanen et al. | Nov 2015 | B2 |
9190263 | Ishikawa et al. | Nov 2015 | B2 |
9196483 | Lee et al. | Nov 2015 | B1 |
9202727 | Dunn et al. | Dec 2015 | B2 |
9228259 | Haukka et al. | Jan 2016 | B2 |
9240412 | Xie et al. | Jan 2016 | B2 |
20010017103 | Takeshita et al. | Aug 2001 | A1 |
20010018267 | Shinriki et al. | Aug 2001 | A1 |
20010019777 | Tanaka et al. | Sep 2001 | A1 |
20010019900 | Hasegawa | Sep 2001 | A1 |
20010028924 | Sherman | Oct 2001 | A1 |
20010046765 | Cappellani et al. | Nov 2001 | A1 |
20010049202 | Maeda et al. | Dec 2001 | A1 |
20020001974 | Chan | Jan 2002 | A1 |
20020011210 | Satoh et al. | Jan 2002 | A1 |
20020014204 | Pyo | Feb 2002 | A1 |
20020064592 | Datta et al. | May 2002 | A1 |
20020076507 | Chiang et al. | Jun 2002 | A1 |
20020079714 | Soucy et al. | Jun 2002 | A1 |
20020088542 | Nishikawa et al. | Jul 2002 | A1 |
20020098627 | Pomarede et al. | Jul 2002 | A1 |
20020108670 | Baker et al. | Aug 2002 | A1 |
20020110991 | Li | Aug 2002 | A1 |
20020114886 | Chou et al. | Aug 2002 | A1 |
20020115252 | Haukka et al. | Aug 2002 | A1 |
20020172768 | Endo et al. | Nov 2002 | A1 |
20020187650 | Blalock et al. | Dec 2002 | A1 |
20020197849 | Mandal | Dec 2002 | A1 |
20030003635 | Paranjpe et al. | Jan 2003 | A1 |
20030010452 | Park et al. | Jan 2003 | A1 |
20030012632 | Saeki | Jan 2003 | A1 |
20030019428 | Ku et al. | Jan 2003 | A1 |
20030019580 | Strang | Jan 2003 | A1 |
20030025146 | Narwankar et al. | Feb 2003 | A1 |
20030040158 | Saitoh | Feb 2003 | A1 |
20030042419 | Katsumata et al. | Mar 2003 | A1 |
20030049375 | Nguyen et al. | Mar 2003 | A1 |
20030054670 | Wang et al. | Mar 2003 | A1 |
20030059535 | Luo et al. | Mar 2003 | A1 |
20030059980 | Chen et al. | Mar 2003 | A1 |
20030066826 | Lee et al. | Apr 2003 | A1 |
20030075925 | Lindfors et al. | Apr 2003 | A1 |
20030082307 | Chung et al. | May 2003 | A1 |
20030091938 | Fairbairn et al. | May 2003 | A1 |
20030094133 | Yoshidome et al. | May 2003 | A1 |
20030111963 | Tolmachev et al. | Jun 2003 | A1 |
20030134038 | Paranjpe | Jul 2003 | A1 |
20030141820 | White et al. | Jul 2003 | A1 |
20030157436 | Manger et al. | Aug 2003 | A1 |
20030168001 | Sneh | Sep 2003 | A1 |
20030170583 | Nakashima | Sep 2003 | A1 |
20030180458 | Sneh | Sep 2003 | A1 |
20030183156 | Dando | Oct 2003 | A1 |
20030192875 | Bieker et al. | Oct 2003 | A1 |
20030198587 | Kaloyeros | Oct 2003 | A1 |
20030209323 | Yokogaki | Nov 2003 | A1 |
20030228772 | Cowans | Dec 2003 | A1 |
20030232138 | Tuominen et al. | Dec 2003 | A1 |
20040009679 | Yeo et al. | Jan 2004 | A1 |
20040013577 | Ganguli et al. | Jan 2004 | A1 |
20040013818 | Moon et al. | Jan 2004 | A1 |
20040016637 | Yang | Jan 2004 | A1 |
20040018307 | Park et al. | Jan 2004 | A1 |
20040018750 | Sophie et al. | Jan 2004 | A1 |
20040023516 | Londergan et al. | Feb 2004 | A1 |
20040029052 | Park et al. | Feb 2004 | A1 |
20040036129 | Forbes et al. | Feb 2004 | A1 |
20040063289 | Ohta | Apr 2004 | A1 |
20040071897 | Verplancken et al. | Apr 2004 | A1 |
20040077182 | Lim et al. | Apr 2004 | A1 |
20040079960 | Shakuda | Apr 2004 | A1 |
20040080697 | Song | Apr 2004 | A1 |
20040082171 | Shin et al. | Apr 2004 | A1 |
20040101622 | Park et al. | May 2004 | A1 |
20040103914 | Cheng et al. | Jun 2004 | A1 |
20040106249 | Huotari | Jun 2004 | A1 |
20040124549 | Curran | Jul 2004 | A1 |
20040134429 | Yamanaka | Jul 2004 | A1 |
20040144980 | Ahn et al. | Jul 2004 | A1 |
20040146644 | Xiao et al. | Jul 2004 | A1 |
20040168627 | Conley et al. | Sep 2004 | A1 |
20040169032 | Murayama et al. | Sep 2004 | A1 |
20040198069 | Metzner et al. | Oct 2004 | A1 |
20040200499 | Harvey et al. | Oct 2004 | A1 |
20040209477 | Buxbaum et al. | Oct 2004 | A1 |
20040212947 | Nguyen | Oct 2004 | A1 |
20040214445 | Shimizu et al. | Oct 2004 | A1 |
20040219793 | Hishiya et al. | Nov 2004 | A1 |
20040221807 | Verghese et al. | Nov 2004 | A1 |
20040247779 | Selvamanickam et al. | Dec 2004 | A1 |
20040261712 | Hayashi et al. | Dec 2004 | A1 |
20040266011 | Lee et al. | Dec 2004 | A1 |
20050003662 | Jursich et al. | Jan 2005 | A1 |
20050008799 | Tomiyasu et al. | Jan 2005 | A1 |
20050019026 | Wang et al. | Jan 2005 | A1 |
20050020071 | Sonobe et al. | Jan 2005 | A1 |
20050023624 | Ahn et al. | Feb 2005 | A1 |
20050034674 | Ono | Feb 2005 | A1 |
20050037154 | Koh et al. | Feb 2005 | A1 |
20050051093 | Makino et al. | Mar 2005 | A1 |
20050054228 | March | Mar 2005 | A1 |
20050059262 | Yin et al. | Mar 2005 | A1 |
20050064207 | Senzaki et al. | Mar 2005 | A1 |
20050064719 | Liu | Mar 2005 | A1 |
20050066893 | Soininen | Mar 2005 | A1 |
20050069651 | Miyoshi | Mar 2005 | A1 |
20050070123 | Hirano | Mar 2005 | A1 |
20050070729 | Kiyomori et al. | Mar 2005 | A1 |
20050072357 | Shero et al. | Apr 2005 | A1 |
20050074983 | Shinriki et al. | Apr 2005 | A1 |
20050092249 | Kilpela et al. | May 2005 | A1 |
20050095770 | Kumagai et al. | May 2005 | A1 |
20050100669 | Kools et al. | May 2005 | A1 |
20050101154 | Huang | May 2005 | A1 |
20050106893 | Wilk | May 2005 | A1 |
20050110069 | Kil et al. | May 2005 | A1 |
20050120962 | Ushioda et al. | Jun 2005 | A1 |
20050123690 | Derderian et al. | Jun 2005 | A1 |
20050133161 | Carpenter et al. | Jun 2005 | A1 |
20050142361 | Nakanishi | Jun 2005 | A1 |
20050145338 | Park et al. | Jul 2005 | A1 |
20050153571 | Senzaki | Jul 2005 | A1 |
20050173003 | Laverdiere et al. | Aug 2005 | A1 |
20050181535 | Yun et al. | Aug 2005 | A1 |
20050187647 | Wang et al. | Aug 2005 | A1 |
20050191828 | Al-Bayati et al. | Sep 2005 | A1 |
20050199013 | Vandroux et al. | Sep 2005 | A1 |
20050208718 | Lim et al. | Sep 2005 | A1 |
20050212119 | Shero | Sep 2005 | A1 |
20050214457 | Schmitt et al. | Sep 2005 | A1 |
20050214458 | Meiere | Sep 2005 | A1 |
20050218462 | Ahn et al. | Oct 2005 | A1 |
20050221618 | AmRhein et al. | Oct 2005 | A1 |
20050223994 | Blomiley et al. | Oct 2005 | A1 |
20050227502 | Schmitt et al. | Oct 2005 | A1 |
20050229848 | Shinriki | Oct 2005 | A1 |
20050229972 | Hoshi et al. | Oct 2005 | A1 |
20050241176 | Shero et al. | Nov 2005 | A1 |
20050241763 | Huang et al. | Nov 2005 | A1 |
20050255257 | Choi et al. | Nov 2005 | A1 |
20050258280 | Goto et al. | Nov 2005 | A1 |
20050260347 | Narwankar et al. | Nov 2005 | A1 |
20050260850 | Loke | Nov 2005 | A1 |
20050263075 | Wang et al. | Dec 2005 | A1 |
20050263932 | Heugel | Dec 2005 | A1 |
20050271813 | Kher et al. | Dec 2005 | A1 |
20050274323 | Seidel et al. | Dec 2005 | A1 |
20050282101 | Adachi | Dec 2005 | A1 |
20050287725 | Kitagawa | Dec 2005 | A1 |
20050287771 | Seamons et al. | Dec 2005 | A1 |
20060013946 | Park et al. | Jan 2006 | A1 |
20060014384 | Lee et al. | Jan 2006 | A1 |
20060014397 | Seamons et al. | Jan 2006 | A1 |
20060016783 | Wu et al. | Jan 2006 | A1 |
20060019033 | Muthukrishnan et al. | Jan 2006 | A1 |
20060019502 | Park et al. | Jan 2006 | A1 |
20060021703 | Umotoy et al. | Feb 2006 | A1 |
20060024439 | Tuominen et al. | Feb 2006 | A2 |
20060046518 | Hill et al. | Mar 2006 | A1 |
20060051520 | Behle et al. | Mar 2006 | A1 |
20060051925 | Ahn et al. | Mar 2006 | A1 |
20060060930 | Metz et al. | Mar 2006 | A1 |
20060062910 | Meiere | Mar 2006 | A1 |
20060063346 | Lee et al. | Mar 2006 | A1 |
20060068121 | Lee et al. | Mar 2006 | A1 |
20060068125 | Radhakrishnan | Mar 2006 | A1 |
20060105566 | Waldfried et al. | May 2006 | A1 |
20060110934 | Fukuchi | May 2006 | A1 |
20060113675 | Chang et al. | Jun 2006 | A1 |
20060113806 | Tsuji et al. | Jun 2006 | A1 |
20060128168 | Ahn et al. | Jun 2006 | A1 |
20060130767 | Herchen | Jun 2006 | A1 |
20060137609 | Puchacz et al. | Jun 2006 | A1 |
20060147626 | Blomberg | Jul 2006 | A1 |
20060148180 | Ahn et al. | Jul 2006 | A1 |
20060163612 | Kouvetakis et al. | Jul 2006 | A1 |
20060172531 | Lin et al. | Aug 2006 | A1 |
20060191555 | Yoshida et al. | Aug 2006 | A1 |
20060193979 | Meiere et al. | Aug 2006 | A1 |
20060199357 | Wan et al. | Sep 2006 | A1 |
20060205223 | Smayling | Sep 2006 | A1 |
20060208215 | Metzner et al. | Sep 2006 | A1 |
20060213439 | Ishizaka | Sep 2006 | A1 |
20060223301 | Vanhaelemeersch et al. | Oct 2006 | A1 |
20060226117 | Bertram et al. | Oct 2006 | A1 |
20060228888 | Lee et al. | Oct 2006 | A1 |
20060236934 | Choi et al. | Oct 2006 | A1 |
20060240574 | Yoshie | Oct 2006 | A1 |
20060240662 | Conley et al. | Oct 2006 | A1 |
20060251827 | Nowak | Nov 2006 | A1 |
20060257563 | Doh et al. | Nov 2006 | A1 |
20060257584 | Derderian et al. | Nov 2006 | A1 |
20060258078 | Lee et al. | Nov 2006 | A1 |
20060258173 | Xiao et al. | Nov 2006 | A1 |
20060260545 | Ramaswamy et al. | Nov 2006 | A1 |
20060264060 | Ramaswamy et al. | Nov 2006 | A1 |
20060264066 | Bartholomew | Nov 2006 | A1 |
20060266289 | Verghese et al. | Nov 2006 | A1 |
20060269692 | Balseanu | Nov 2006 | A1 |
20060278524 | Stowell | Dec 2006 | A1 |
20070006806 | Imai | Jan 2007 | A1 |
20070010072 | Bailey et al. | Jan 2007 | A1 |
20070020953 | Tsai et al. | Jan 2007 | A1 |
20070022954 | Iizuka et al. | Feb 2007 | A1 |
20070028842 | Inagawa et al. | Feb 2007 | A1 |
20070031598 | Okuyama et al. | Feb 2007 | A1 |
20070031599 | Gschwandtner et al. | Feb 2007 | A1 |
20070032082 | Ramaswamy et al. | Feb 2007 | A1 |
20070037412 | Dip et al. | Feb 2007 | A1 |
20070042117 | Kuppurao et al. | Feb 2007 | A1 |
20070049053 | Mahajani | Mar 2007 | A1 |
20070054499 | Jang | Mar 2007 | A1 |
20070059948 | Metzner et al. | Mar 2007 | A1 |
20070062453 | Ishikawa | Mar 2007 | A1 |
20070065578 | McDougall | Mar 2007 | A1 |
20070066010 | Ando | Mar 2007 | A1 |
20070066079 | Kloster et al. | Mar 2007 | A1 |
20070077355 | Chacin et al. | Apr 2007 | A1 |
20070082132 | Hiroshi Shinriki | Apr 2007 | A1 |
20070084405 | Kim | Apr 2007 | A1 |
20070096194 | Streck et al. | May 2007 | A1 |
20070098527 | Hall et al. | May 2007 | A1 |
20070107845 | Ishizawa et al. | May 2007 | A1 |
20070111545 | Lee et al. | May 2007 | A1 |
20070116873 | Li et al. | May 2007 | A1 |
20070123037 | Lee et al. | May 2007 | A1 |
20070125762 | Cui et al. | Jun 2007 | A1 |
20070128538 | Fairbairn et al. | Jun 2007 | A1 |
20070134942 | Ahn et al. | Jun 2007 | A1 |
20070146621 | Yeom | Jun 2007 | A1 |
20070148990 | DeBoer et al. | Jun 2007 | A1 |
20070155138 | Tomasini et al. | Jul 2007 | A1 |
20070158026 | Amikura | Jul 2007 | A1 |
20070163440 | Kim et al. | Jul 2007 | A1 |
20070166457 | Yamoto et al. | Jul 2007 | A1 |
20070166966 | Todd et al. | Jul 2007 | A1 |
20070166999 | Vaartstra | Jul 2007 | A1 |
20070173071 | Afzali-Ardakani et al. | Jul 2007 | A1 |
20070175393 | Nishimura et al. | Aug 2007 | A1 |
20070175397 | Tomiyasu et al. | Aug 2007 | A1 |
20070186952 | Honda et al. | Aug 2007 | A1 |
20070207275 | Nowak et al. | Sep 2007 | A1 |
20070209590 | Li | Sep 2007 | A1 |
20070210890 | Hsu et al. | Sep 2007 | A1 |
20070215048 | Suzuki et al. | Sep 2007 | A1 |
20070218200 | Suzuki et al. | Sep 2007 | A1 |
20070218705 | Matsuki et al. | Sep 2007 | A1 |
20070224777 | Hamelin | Sep 2007 | A1 |
20070224833 | Morisada et al. | Sep 2007 | A1 |
20070232031 | Singh et al. | Oct 2007 | A1 |
20070232071 | Balseanu et al. | Oct 2007 | A1 |
20070232501 | Tonomura | Oct 2007 | A1 |
20070234955 | Suzuki et al. | Oct 2007 | A1 |
20070237697 | Clark | Oct 2007 | A1 |
20070241688 | DeVincentis et al. | Oct 2007 | A1 |
20070248767 | Okura | Oct 2007 | A1 |
20070249131 | Allen et al. | Oct 2007 | A1 |
20070251444 | Gros-Jean et al. | Nov 2007 | A1 |
20070252244 | Srividya et al. | Nov 2007 | A1 |
20070252532 | DeVincentis et al. | Nov 2007 | A1 |
20070264807 | Leone et al. | Nov 2007 | A1 |
20070275166 | Thridandam et al. | Nov 2007 | A1 |
20070277735 | Mokhlesi et al. | Dec 2007 | A1 |
20070281496 | Ingle et al. | Dec 2007 | A1 |
20070298362 | Rocha-Alvarez et al. | Dec 2007 | A1 |
20080003824 | Padhi et al. | Jan 2008 | A1 |
20080003838 | Haukka et al. | Jan 2008 | A1 |
20080006208 | Ueno et al. | Jan 2008 | A1 |
20080023436 | Gros-Jean et al. | Jan 2008 | A1 |
20080026574 | Brcka | Jan 2008 | A1 |
20080026597 | Munro et al. | Jan 2008 | A1 |
20080029790 | Ahn et al. | Feb 2008 | A1 |
20080036354 | Letz et al. | Feb 2008 | A1 |
20080038485 | Lukas | Feb 2008 | A1 |
20080054332 | Kim et al. | Mar 2008 | A1 |
20080054813 | Espiau et al. | Mar 2008 | A1 |
20080057659 | Forbes et al. | Mar 2008 | A1 |
20080061667 | Gaertner et al. | Mar 2008 | A1 |
20080066778 | Matsushita et al. | Mar 2008 | A1 |
20080069955 | Hong et al. | Mar 2008 | A1 |
20080075881 | Won et al. | Mar 2008 | A1 |
20080076266 | Fukazawa et al. | Mar 2008 | A1 |
20080081104 | Hasebe et al. | Apr 2008 | A1 |
20080081113 | Clark | Apr 2008 | A1 |
20080081121 | Morita et al. | Apr 2008 | A1 |
20080085226 | Fondurulia et al. | Apr 2008 | A1 |
20080092815 | Chen et al. | Apr 2008 | A1 |
20080113094 | Casper | May 2008 | A1 |
20080113096 | Mahajani | May 2008 | A1 |
20080113097 | Mahajani et al. | May 2008 | A1 |
20080124197 | van der Meulen et al. | May 2008 | A1 |
20080124908 | Forbes et al. | May 2008 | A1 |
20080124946 | Xiao et al. | May 2008 | A1 |
20080133154 | Krauss et al. | Jun 2008 | A1 |
20080149031 | Chu et al. | Jun 2008 | A1 |
20080152463 | Chidambaram et al. | Jun 2008 | A1 |
20080153311 | Padhi et al. | Jun 2008 | A1 |
20080173240 | Furukawahara | Jul 2008 | A1 |
20080173326 | Gu et al. | Jul 2008 | A1 |
20080176375 | Erben et al. | Jul 2008 | A1 |
20080178805 | Paterson et al. | Jul 2008 | A1 |
20080179715 | Coppa | Jul 2008 | A1 |
20080182075 | Chopra | Jul 2008 | A1 |
20080182390 | Lemmi et al. | Jul 2008 | A1 |
20080191193 | Li et al. | Aug 2008 | A1 |
20080199977 | Weigel et al. | Aug 2008 | A1 |
20080203487 | Hohage et al. | Aug 2008 | A1 |
20080211423 | Shinmen et al. | Sep 2008 | A1 |
20080211526 | Shinma | Sep 2008 | A1 |
20080216077 | Emani et al. | Sep 2008 | A1 |
20080220619 | Matsushita et al. | Sep 2008 | A1 |
20080224240 | Ahn et al. | Sep 2008 | A1 |
20080233288 | Clark | Sep 2008 | A1 |
20080237572 | Chui et al. | Oct 2008 | A1 |
20080241384 | Jeong | Oct 2008 | A1 |
20080242116 | Clark | Oct 2008 | A1 |
20080248310 | Kim et al. | Oct 2008 | A1 |
20080257494 | Hayashi et al. | Oct 2008 | A1 |
20080261413 | Mahajani | Oct 2008 | A1 |
20080264337 | Sano et al. | Oct 2008 | A1 |
20080267598 | Nakamura | Oct 2008 | A1 |
20080277715 | Ohmi et al. | Nov 2008 | A1 |
20080282970 | Heys et al. | Nov 2008 | A1 |
20080295872 | Riker et al. | Dec 2008 | A1 |
20080299326 | Fukazawa | Dec 2008 | A1 |
20080302303 | Choi et al. | Dec 2008 | A1 |
20080305246 | Choi et al. | Dec 2008 | A1 |
20080305443 | Nakamura | Dec 2008 | A1 |
20080315292 | Ji et al. | Dec 2008 | A1 |
20080317972 | Hendriks | Dec 2008 | A1 |
20090000550 | Tran et al. | Jan 2009 | A1 |
20090000551 | Choi et al. | Jan 2009 | A1 |
20090011608 | Nabatame | Jan 2009 | A1 |
20090020072 | Mizunaga et al. | Jan 2009 | A1 |
20090023229 | Matsushita | Jan 2009 | A1 |
20090029528 | Sanchez et al. | Jan 2009 | A1 |
20090029564 | Yamashita et al. | Jan 2009 | A1 |
20090033907 | Watson | Feb 2009 | A1 |
20090035947 | Horii | Feb 2009 | A1 |
20090041952 | Yoon et al. | Feb 2009 | A1 |
20090041984 | Mayers et al. | Feb 2009 | A1 |
20090045829 | Awazu | Feb 2009 | A1 |
20090050621 | Awazu | Feb 2009 | A1 |
20090061644 | Chiang et al. | Mar 2009 | A1 |
20090061647 | Mallick et al. | Mar 2009 | A1 |
20090085156 | Dewey et al. | Apr 2009 | A1 |
20090090382 | Morisada | Apr 2009 | A1 |
20090093094 | Ye et al. | Apr 2009 | A1 |
20090095221 | Tam et al. | Apr 2009 | A1 |
20090104789 | Mallick et al. | Apr 2009 | A1 |
20090107404 | Ogliari et al. | Apr 2009 | A1 |
20090120580 | Kagoshima et al. | May 2009 | A1 |
20090122293 | Shibazaki | May 2009 | A1 |
20090136668 | Gregg et al. | May 2009 | A1 |
20090136683 | Fukasawa et al. | May 2009 | A1 |
20090139657 | Lee et al. | Jun 2009 | A1 |
20090142935 | Fukuzawa et al. | Jun 2009 | A1 |
20090146322 | Weling et al. | Jun 2009 | A1 |
20090156015 | Park et al. | Jun 2009 | A1 |
20090209081 | Matero | Aug 2009 | A1 |
20090211523 | Kuppurao et al. | Aug 2009 | A1 |
20090211525 | Sarigiannis et al. | Aug 2009 | A1 |
20090239386 | Suzaki et al. | Sep 2009 | A1 |
20090242957 | Ma et al. | Oct 2009 | A1 |
20090246374 | Vukovic | Oct 2009 | A1 |
20090246399 | Goundar | Oct 2009 | A1 |
20090246971 | Reid et al. | Oct 2009 | A1 |
20090250955 | Aoki | Oct 2009 | A1 |
20090261331 | Yang et al. | Oct 2009 | A1 |
20090269506 | Okura et al. | Oct 2009 | A1 |
20090275205 | Kiehlbauch et al. | Nov 2009 | A1 |
20090277510 | Shikata | Nov 2009 | A1 |
20090283041 | Tomiyasu et al. | Nov 2009 | A1 |
20090283217 | Lubomirsky et al. | Nov 2009 | A1 |
20090286400 | Heo et al. | Nov 2009 | A1 |
20090286402 | Xia et al. | Nov 2009 | A1 |
20090289300 | Sasaki et al. | Nov 2009 | A1 |
20090304558 | Patton | Dec 2009 | A1 |
20090311857 | Todd et al. | Dec 2009 | A1 |
20100001409 | Humbert et al. | Jan 2010 | A1 |
20100006031 | Choi et al. | Jan 2010 | A1 |
20100014479 | Kim | Jan 2010 | A1 |
20100015813 | McGinnis et al. | Jan 2010 | A1 |
20100024727 | Kim et al. | Feb 2010 | A1 |
20100025796 | Dabiran | Feb 2010 | A1 |
20100040441 | Obikane | Feb 2010 | A1 |
20100041179 | Lee | Feb 2010 | A1 |
20100041243 | Cheng et al. | Feb 2010 | A1 |
20100055312 | Kato et al. | Mar 2010 | A1 |
20100055442 | Kellock | Mar 2010 | A1 |
20100075507 | Chang et al. | Mar 2010 | A1 |
20100089320 | Kim | Apr 2010 | A1 |
20100093187 | Lee et al. | Apr 2010 | A1 |
20100102417 | Ganguli et al. | Apr 2010 | A1 |
20100116209 | Kato | May 2010 | A1 |
20100124610 | Aikawa et al. | May 2010 | A1 |
20100124618 | Kobayashi et al. | May 2010 | A1 |
20100124621 | Kobayashi et al. | May 2010 | A1 |
20100126605 | Stones | May 2010 | A1 |
20100130017 | Luo et al. | May 2010 | A1 |
20100134023 | Mills | Jun 2010 | A1 |
20100136216 | Tsuei et al. | Jun 2010 | A1 |
20100140221 | Kikuchi | Jun 2010 | A1 |
20100144162 | Lee et al. | Jun 2010 | A1 |
20100151206 | Wu et al. | Jun 2010 | A1 |
20100159638 | Jeong et al. | Jun 2010 | A1 |
20100162752 | Tabata et al. | Jul 2010 | A1 |
20100170441 | Won et al. | Jul 2010 | A1 |
20100178137 | Chintalapati et al. | Jul 2010 | A1 |
20100178423 | Shimizu et al. | Jul 2010 | A1 |
20100184302 | Lee et al. | Jul 2010 | A1 |
20100193501 | Zucker et al. | Aug 2010 | A1 |
20100195392 | Freeman | Aug 2010 | A1 |
20100221452 | Kang | Sep 2010 | A1 |
20100230051 | Iizuka | Sep 2010 | A1 |
20100233886 | Yang et al. | Sep 2010 | A1 |
20100243166 | Hayashi et al. | Sep 2010 | A1 |
20100244688 | Braun et al. | Sep 2010 | A1 |
20100255198 | Cleary et al. | Oct 2010 | A1 |
20100255625 | De Vries | Oct 2010 | A1 |
20100259152 | Yasuda et al. | Oct 2010 | A1 |
20100270675 | Harada | Oct 2010 | A1 |
20100275846 | Kitagawa | Nov 2010 | A1 |
20100285319 | Kwak et al. | Nov 2010 | A1 |
20100294199 | Tran et al. | Nov 2010 | A1 |
20100301752 | Bakre et al. | Dec 2010 | A1 |
20100304047 | Yang et al. | Dec 2010 | A1 |
20100307415 | Shero et al. | Dec 2010 | A1 |
20100317198 | Antonelli | Dec 2010 | A1 |
20100322604 | Fondurulia et al. | Dec 2010 | A1 |
20110000619 | Suh | Jan 2011 | A1 |
20110006402 | Zhou | Jan 2011 | A1 |
20110006406 | Urbanowicz et al. | Jan 2011 | A1 |
20110014795 | Lee | Jan 2011 | A1 |
20110027999 | Sparks et al. | Feb 2011 | A1 |
20110034039 | Liang et al. | Feb 2011 | A1 |
20110048642 | Mihara et al. | Mar 2011 | A1 |
20110052833 | Hanawa et al. | Mar 2011 | A1 |
20110056513 | Hombach et al. | Mar 2011 | A1 |
20110056626 | Brown et al. | Mar 2011 | A1 |
20110061810 | Ganguly et al. | Mar 2011 | A1 |
20110070380 | Shero et al. | Mar 2011 | A1 |
20110081519 | Dillingh | Apr 2011 | A1 |
20110086516 | Lee et al. | Apr 2011 | A1 |
20110089469 | Merckling | Apr 2011 | A1 |
20110097901 | Banna et al. | Apr 2011 | A1 |
20110107512 | Gilbert | May 2011 | A1 |
20110108194 | Yoshioka et al. | May 2011 | A1 |
20110108741 | Ingram | May 2011 | A1 |
20110108929 | Meng | May 2011 | A1 |
20110117490 | Bae et al. | May 2011 | A1 |
20110117737 | Agarwala et al. | May 2011 | A1 |
20110124196 | Lee | May 2011 | A1 |
20110139748 | Donnelly et al. | Jun 2011 | A1 |
20110143032 | Vrtis et al. | Jun 2011 | A1 |
20110143461 | Fish et al. | Jun 2011 | A1 |
20110159202 | Matsushita et al. | Jun 2011 | A1 |
20110159673 | Hanawa et al. | Jun 2011 | A1 |
20110175011 | Ehrne et al. | Jul 2011 | A1 |
20110183079 | Jackson et al. | Jul 2011 | A1 |
20110183269 | Zhu | Jul 2011 | A1 |
20110192820 | Yeom et al. | Aug 2011 | A1 |
20110198736 | Shero et al. | Aug 2011 | A1 |
20110210468 | Shannon et al. | Sep 2011 | A1 |
20110220874 | Hanrath | Sep 2011 | A1 |
20110236600 | Fox et al. | Sep 2011 | A1 |
20110239936 | Suzaki et al. | Oct 2011 | A1 |
20110254052 | Kouvetakis et al. | Oct 2011 | A1 |
20110256675 | Avouris | Oct 2011 | A1 |
20110256726 | Lavoie et al. | Oct 2011 | A1 |
20110256727 | Beynet et al. | Oct 2011 | A1 |
20110256734 | Hausmann et al. | Oct 2011 | A1 |
20110265549 | Cruse et al. | Nov 2011 | A1 |
20110265951 | Xu et al. | Nov 2011 | A1 |
20110275166 | Shero et al. | Nov 2011 | A1 |
20110281417 | Gordon et al. | Nov 2011 | A1 |
20110283933 | Makarov et al. | Nov 2011 | A1 |
20110294075 | Chen et al. | Dec 2011 | A1 |
20110308460 | Hong et al. | Dec 2011 | A1 |
20120003500 | Yoshida et al. | Jan 2012 | A1 |
20120006489 | Okita | Jan 2012 | A1 |
20120024479 | Palagashvili et al. | Feb 2012 | A1 |
20120032311 | Gates et al. | Feb 2012 | A1 |
20120043556 | Dube et al. | Feb 2012 | A1 |
20120052681 | Marsh | Mar 2012 | A1 |
20120070136 | Koelmel et al. | Mar 2012 | A1 |
20120070997 | Larson | Mar 2012 | A1 |
20120090704 | Laverdiere et al. | Apr 2012 | A1 |
20120098107 | Raisanen et al. | Apr 2012 | A1 |
20120100464 | Kageyama | Apr 2012 | A1 |
20120103264 | Choi et al. | May 2012 | A1 |
20120103939 | Wu et al. | May 2012 | A1 |
20120107607 | Takaki et al. | May 2012 | A1 |
20120114877 | Lee | May 2012 | A1 |
20120121823 | Chhabra | May 2012 | A1 |
20120122302 | Weidman et al. | May 2012 | A1 |
20120128897 | Xiao et al. | May 2012 | A1 |
20120135145 | Je et al. | May 2012 | A1 |
20120156108 | Fondurulia et al. | Jun 2012 | A1 |
20120160172 | Wamura et al. | Jun 2012 | A1 |
20120164327 | Sato | Jun 2012 | A1 |
20120164837 | Tan et al. | Jun 2012 | A1 |
20120164842 | Watanabe | Jun 2012 | A1 |
20120171391 | Won | Jul 2012 | A1 |
20120171874 | Thridandam et al. | Jul 2012 | A1 |
20120207456 | Kim et al. | Aug 2012 | A1 |
20120212121 | Lin | Aug 2012 | A1 |
20120214318 | Fukazawa et al. | Aug 2012 | A1 |
20120220139 | Lee et al. | Aug 2012 | A1 |
20120225561 | Watanabe | Sep 2012 | A1 |
20120240858 | Taniyama et al. | Sep 2012 | A1 |
20120263876 | Haukka et al. | Oct 2012 | A1 |
20120270339 | Xie et al. | Oct 2012 | A1 |
20120270393 | Pore et al. | Oct 2012 | A1 |
20120289053 | Holland et al. | Nov 2012 | A1 |
20120295427 | Bauer | Nov 2012 | A1 |
20120304935 | Oosterlaken et al. | Dec 2012 | A1 |
20120305196 | Mori et al. | Dec 2012 | A1 |
20120315113 | Hiroki | Dec 2012 | A1 |
20120318334 | Bedell et al. | Dec 2012 | A1 |
20120321786 | Satitpunwaycha et al. | Dec 2012 | A1 |
20120322252 | Son et al. | Dec 2012 | A1 |
20120325148 | Yamagishi et al. | Dec 2012 | A1 |
20120328780 | Yamagishi et al. | Dec 2012 | A1 |
20130005122 | Schwarzenbach et al. | Jan 2013 | A1 |
20130011983 | Tsai | Jan 2013 | A1 |
20130014697 | Kanayama | Jan 2013 | A1 |
20130014896 | Shoji et al. | Jan 2013 | A1 |
20130019944 | Hekmatshoar-Tabari et al. | Jan 2013 | A1 |
20130019945 | Hekmatshoar-Tabari et al. | Jan 2013 | A1 |
20130023129 | Reed | Jan 2013 | A1 |
20130048606 | Mao et al. | Feb 2013 | A1 |
20130064973 | Chen et al. | Mar 2013 | A1 |
20130068970 | Matsushita | Mar 2013 | A1 |
20130078392 | Xiao et al. | Mar 2013 | A1 |
20130081702 | Mohammed et al. | Apr 2013 | A1 |
20130084156 | Shimamoto | Apr 2013 | A1 |
20130084714 | Oka et al. | Apr 2013 | A1 |
20130104988 | Yednak et al. | May 2013 | A1 |
20130104992 | Yednak et al. | May 2013 | A1 |
20130115383 | Lu et al. | May 2013 | A1 |
20130115763 | Takamure | May 2013 | A1 |
20130122712 | Kim et al. | May 2013 | A1 |
20130126515 | Shero et al. | May 2013 | A1 |
20130129577 | Halpin et al. | May 2013 | A1 |
20130134148 | Tachikawa | May 2013 | A1 |
20130168354 | Kanarik | Jul 2013 | A1 |
20130180448 | Sakaue et al. | Jul 2013 | A1 |
20130183814 | Huang et al. | Jul 2013 | A1 |
20130210241 | Lavoie et al. | Aug 2013 | A1 |
20130217239 | Mallick et al. | Aug 2013 | A1 |
20130217240 | Mallick et al. | Aug 2013 | A1 |
20130217241 | Underwood et al. | Aug 2013 | A1 |
20130217243 | Underwood et al. | Aug 2013 | A1 |
20130224964 | Fukazawa | Aug 2013 | A1 |
20130230814 | Dunn et al. | Sep 2013 | A1 |
20130256838 | Sanchez et al. | Oct 2013 | A1 |
20130264659 | Jung | Oct 2013 | A1 |
20130288480 | Sanchez et al. | Oct 2013 | A1 |
20130292047 | Tian et al. | Nov 2013 | A1 |
20130292676 | Milligan et al. | Nov 2013 | A1 |
20130292807 | Raisanen et al. | Nov 2013 | A1 |
20130295779 | Chandra et al. | Nov 2013 | A1 |
20130319290 | Xiao et al. | Dec 2013 | A1 |
20130323435 | Xiao et al. | Dec 2013 | A1 |
20130330165 | Wimplinger et al. | Dec 2013 | A1 |
20130330911 | Huang et al. | Dec 2013 | A1 |
20130330933 | Fukazawa et al. | Dec 2013 | A1 |
20130337583 | Kobayashi et al. | Dec 2013 | A1 |
20140000843 | Dunn et al. | Jan 2014 | A1 |
20140014642 | Elliot et al. | Jan 2014 | A1 |
20140014644 | Akiba et al. | Jan 2014 | A1 |
20140020619 | Vincent et al. | Jan 2014 | A1 |
20140027884 | Tang et al. | Jan 2014 | A1 |
20140033978 | Adachi et al. | Feb 2014 | A1 |
20140036274 | Marquardt et al. | Feb 2014 | A1 |
20140048765 | Ma et al. | Feb 2014 | A1 |
20140056679 | Yamabe et al. | Feb 2014 | A1 |
20140060147 | Sarin et al. | Mar 2014 | A1 |
20140062304 | Nakano et al. | Mar 2014 | A1 |
20140067110 | Lawson et al. | Mar 2014 | A1 |
20140073143 | Alokozai et al. | Mar 2014 | A1 |
20140077240 | Roucka et al. | Mar 2014 | A1 |
20140084341 | Weeks | Mar 2014 | A1 |
20140087544 | Tolle | Mar 2014 | A1 |
20140094027 | Azumo et al. | Apr 2014 | A1 |
20140096716 | Chung et al. | Apr 2014 | A1 |
20140099798 | Tsuji | Apr 2014 | A1 |
20140103145 | White et al. | Apr 2014 | A1 |
20140116335 | Tsuji et al. | May 2014 | A1 |
20140120487 | Kaneko | May 2014 | A1 |
20140127907 | Yang | May 2014 | A1 |
20140141625 | Fukazawa et al. | May 2014 | A1 |
20140159170 | Raisanen et al. | Jun 2014 | A1 |
20140174354 | Arai | Jun 2014 | A1 |
20140175054 | Carlson et al. | Jun 2014 | A1 |
20140182053 | Huang | Jul 2014 | A1 |
20140217065 | Winkler et al. | Aug 2014 | A1 |
20140220247 | Haukka et al. | Aug 2014 | A1 |
20140225065 | Rachmady et al. | Aug 2014 | A1 |
20140227072 | Lee et al. | Aug 2014 | A1 |
20140251953 | Winkler et al. | Sep 2014 | A1 |
20140251954 | Winkler et al. | Sep 2014 | A1 |
20140283747 | Kasai et al. | Sep 2014 | A1 |
20140346650 | Raisanen et al. | Nov 2014 | A1 |
20140349033 | Nonaka et al. | Nov 2014 | A1 |
20140363980 | Kawamata et al. | Dec 2014 | A1 |
20140363985 | Jang et al. | Dec 2014 | A1 |
20140367043 | Bishara et al. | Dec 2014 | A1 |
20150004316 | Thompson et al. | Jan 2015 | A1 |
20150004317 | Dussarrat et al. | Jan 2015 | A1 |
20150007770 | Chandrasekharan et al. | Jan 2015 | A1 |
20150014632 | Kim et al. | Jan 2015 | A1 |
20150021599 | Ridgeway | Jan 2015 | A1 |
20150024609 | Milligan et al. | Jan 2015 | A1 |
20150048485 | Tolle | Feb 2015 | A1 |
20150078874 | Sansoni | Mar 2015 | A1 |
20150086316 | Greenberg | Mar 2015 | A1 |
20150091057 | Xie | Apr 2015 | A1 |
20150096973 | Dunn et al. | Apr 2015 | A1 |
20150099072 | Takamure et al. | Apr 2015 | A1 |
20150132212 | Winkler | May 2015 | A1 |
20150140210 | Jung et al. | May 2015 | A1 |
20150147483 | Fukazawa | May 2015 | A1 |
20150147877 | Jung | May 2015 | A1 |
20150167159 | Halpin et al. | Jun 2015 | A1 |
20150170954 | Agarwal | Jun 2015 | A1 |
20150174768 | Rodnick | Jun 2015 | A1 |
20150184291 | Alokozai et al. | Jul 2015 | A1 |
20150187568 | Pettinger et al. | Jul 2015 | A1 |
20150217456 | Tsuji et al. | Aug 2015 | A1 |
20150240359 | Jdira et al. | Aug 2015 | A1 |
20150267295 | Hill et al. | Sep 2015 | A1 |
20150267297 | Shiba | Sep 2015 | A1 |
20150267299 | Hawkins | Sep 2015 | A1 |
20150267301 | Hill et al. | Sep 2015 | A1 |
20150284848 | Nakano et al. | Oct 2015 | A1 |
20150287626 | Arai | Oct 2015 | A1 |
20150308586 | Shugrue et al. | Oct 2015 | A1 |
20150315704 | Nakano et al. | Nov 2015 | A1 |
20160013024 | Milligan et al. | Jan 2016 | A1 |
20160024656 | White et al. | Jan 2016 | A1 |
20160051964 | Tolle et al. | Feb 2016 | A1 |
Number | Date | Country |
---|---|---|
1563483 | Jan 2005 | CN |
101330015 | Dec 2008 | CN |
101522943 | Sep 2009 | CN |
101423937 | Sep 2011 | CN |
102008052750 | Jun 2009 | DE |
2036600 | Mar 2009 | EP |
2426233 | Jul 2012 | EP |
03-044472 | Feb 1991 | JP |
H04115531 | Apr 1992 | JP |
06-53210 | Feb 1994 | JP |
07-130731 | May 1995 | JP |
07-034936 | Aug 1995 | JP |
7-272694 | Oct 1995 | JP |
H07283149 | Oct 1995 | JP |
08-181135 | Jul 1996 | JP |
H08335558 | Dec 1996 | JP |
10-064696 | Mar 1998 | JP |
10-0261620 | Sep 1998 | JP |
2845163 | Jan 1999 | JP |
2001-15698 | Jan 2001 | JP |
2001342570 | Dec 2001 | JP |
2004014952 | Jan 2004 | JP |
2004091848 | Mar 2004 | JP |
2004128019 | Apr 2004 | JP |
2004134553 | Apr 2004 | JP |
2004294638 | Oct 2004 | JP |
2004310019 | Nov 2004 | JP |
2004538374 | Dec 2004 | JP |
2005507030 | Mar 2005 | JP |
2006186271 | Jul 2006 | JP |
3140111 | Mar 2008 | JP |
2008060304 | Mar 2008 | JP |
2008527748 | Jul 2008 | JP |
2008202107 | Sep 2008 | JP |
2009016815 | Jan 2009 | JP |
2009099938 | May 2009 | JP |
2010067940 | Mar 2010 | JP |
2010097834 | Apr 2010 | JP |
2010205967 | Sep 2010 | JP |
2010251444 | Oct 2010 | JP |
2012089837 | May 2012 | JP |
2012146939 | Aug 2012 | JP |
20100020834 | Feb 2010 | KR |
I226380 | Jan 2005 | TW |
200701301 | Jan 2007 | TW |
9832893 | Jul 1998 | WO |
2004008827 | Jan 2004 | WO |
2004010467 | Jan 2004 | WO |
2006054854 | May 2006 | WO |
2006056091 | Jun 2006 | WO |
2006078666 | Jul 2006 | WO |
2006080782 | Aug 2006 | WO |
2006101857 | Sep 2006 | WO |
2007140376 | Dec 2007 | WO |
2010039363 | Apr 2010 | WO |
2010118051 | Jan 2011 | WO |
2011019950 | Feb 2011 | WO |
2013078065 | May 2013 | WO |
2013078066 | May 2013 | WO |
Entry |
---|
USPTO; Office Action dated Aug. 27, 2010 in U.S. Appl. No. 12/118,596. |
USPTO; Office Action dated Feb. 15, 2011 in U.S. Appl. No. 12/118,596. |
USPTO; Notice of Allowance dated Aug. 4, 2011 in U.S. Appl. No. 12/118,596. |
USPTO; Non-Final Office Action dated Apr. 1, 2010 in U.S. Appl. No. 12/357,174. |
USPTO; Final Office Action dated Sep. 1, 2010 in U.S. Appl. No. 12/357,174. |
USPTO; Notice of Allowance dated Dec. 13, 2010 in U.S. Appl. No. 12/357,174. |
USPTO; Non-Final Office Action dated Dec. 29, 2010 in U.S. Appl. No. 12/362,023. |
USPTO; Non-Final Office Action dated Jul. 26, 2011 in U.S. Appl. No. 12/416,809. |
USPTO; Final Office Action dated Dec. 6, 2011 in U.S. Appl. No. 12/416,809. |
USPTO; Notice of Allowance dated Jun. 16, 2011 in U.S. Appl. No. 12/430,751. |
USPTO; Notice of Allowance dated Jul. 27, 2011 in U.S. Appl. No. 12/430,751. |
USPTO; Notice of Allowance dated Oct. 1, 2010 in U.S. Appl. No. 12/467,017. |
USPTO; Non-Final Office Action dated Mar. 18, 2010 in U.S. Appl. No. 12/489,252. |
USPTO; Notice of Allowance dated Sep. 2, 2010 in U.S. Appl. No. 12/489,252. |
USPTO; Non-Final Office Action dated Dec. 15, 2010 in U.S. Appl. No. 12/553,759. |
USPTO; Final Office Action dated May 4, 2011 in U.S. Appl. No. 12/553,759. |
USPTO; Non-Final Office Action dated Sep. 6, 2011 in U.S. Appl. No. 12/553,759. |
USPTO; Notice of Allowance dated Jan. 24, 2012 in U.S. Appl. No. 12/553,759. |
USPTO; Non-Final Office Action dated Oct. 19, 2012 in U.S. Appl. No. 12/618,355. |
USPTO; Final Office Action dated May 8, 2013 in U.S. Appl. No. 12/618,355. |
USPTO; Non-Final Office Action dated Apr. 8, 2015 in U.S. Appl. No. 12/618,355. |
USPTO; Final Office Action dated Oct. 22, 2015 in U.S. Appl. No. 12/618,355. |
USPTO; Non-Final Office Action dated Feb. 16, 2012 in U.S. Appl. No. 12/618,419. |
USPTO; Final Office Action dated Jun. 22, 2012 in U.S. Appl. No. 12/618,419. |
USPTO; Non-Final Office Action dated Nov. 27, 2012 in U.S. Appl. No. 12/618,419. |
USPTO; Notice of Allowance dated Apr. 12, 2013 in U.S. Appl. No. 12/618,419. |
USPTO; Non-Final Office Action dated Dec. 6, 2011 in U.S. Appl. No. 12/718,731. |
USPTO; Notice of Allowance dated Mar. 16, 2012 in U.S. Appl. No. 12/718,731. |
USPTO; Restriction Requirement dated Jan. 15, 2013 in U.S. Appl. No. 12/754,223. |
USPTO; Office Action dated Feb. 26, 2013 in U.S. Appl. No. 12/754,223. |
USPTO; Final Office Action dated Jun. 28, 2013 in U.S. Appl. No. 12/754,223. |
USPTO; Office Action dated Feb. 25, 2014 in U.S. Appl. No. 12/754,223. |
USPTO; Final Office Action dated Jul. 14, 2014 in U.S. Appl. No. 12/754,223. |
USPTO; Non-Final Office Action dated Mar. 25, 2015 in U.S. Appl. No. 12/754,223. |
USPTO; Final Office Action dated Aug. 12, 2015 in U.S. Appl. No. 12/754,223. |
USPTO; Office Action dated Apr. 23, 2013 in U.S. Appl. No. 12/763,037. |
USPTO; Final Office Action dated Oct. 21, 2013 in U.S. Appl. No. 12/763,037. |
USPTO; Office Action dated Oct. 8, 2014 in U.S. Appl. No. 12/763,037. |
USPTO; Notice of Allowance dated Jan. 27, 2015 in U.S. Appl. No. 12/763,037. |
USPTO; Non-Final Office Action dated Jan. 24, 2011 in U.S. Appl. No. 12/778,808. |
USPTO; Notice of Allowance dated May 9, 2011 in U.S. Appl. No. 12/778,808. |
USPTO; Notice of Allowance dated Oct. 12, 2012 in U.S. Appl. No. 12/832,739. |
USPTO; Non-Final Office Action dated Oct. 16, 2012 in U.S. Appl. No. 12/847,848. |
USPTO; Final Office Action dated Apr. 22, 2013 in U.S. Appl. No. 12/847,848. |
USPTO; Notice of Allowance dated Jan. 16, 2014 in U.S. Appl. No. 12/847,848. |
USPTO; Restriction Requirement dated Sep. 25, 2012 in U.S. Appl. No. 12/854,818. |
USPTO; Office Action dated Dec. 6, 2012 in U.S. Appl. No. 12/854,818. |
USPTO; Final Office Action dated Mar. 13, 2013 in U.S. Appl. No. 12/854,818. |
USPTO; Office Action dated Aug. 30, 2013 in U.S. Appl. No. 12/854,818. |
USPTO; Final Office Action dated Mar. 26, 2014 in U.S. Appl. No. 12/854,818. |
USPTO; Office Action dated Jun. 3, 2014 in U.S. Appl. No. 12/854,818. |
USPTO; Non-Final Office Action dated Jul. 11, 2012 in U.S. Appl. No. 12/875,889. |
USPTO; Notice of Allowance dated Jan. 4, 2013 in U.S. Appl. No. 12/875,889. |
USPTO; Notice of Allowance dated Jan. 9, 2012 in U.S. Appl. No. 12/901,323. |
USPTO; Non-Final Office Action dated Nov. 20, 2013 in U.S. Appl. No. 12/910,607. |
USPTO; Final Office Action dated Apr. 28, 2014 in U.S. Appl. No. 12/910,607. |
USPTO; Notice of Allowance dated Aug. 15, 2014 in U.S. Appl. No. 12/910,607. |
USPTO; Non-Final Office Action dated Oct. 24, 2012 in U.S. Appl. No. 12/940,906. |
USPTO; Final Office Action dated Feb. 13, 2013 in U.S. Appl. No. 12/940,906. |
USPTO; Notice of Allowance dated Apr. 23, 2013 in U.S. Appl. No. 12/940,906. |
USPTO; Non-Final Office Action dated Dec. 7, 2012 in U.S. Appl. No. 12/953,870. |
USPTO; Final Office Action dated Apr. 22, 2013 in U.S. Appl. No. 12/953,870. |
USPTO; Non-Final Office Action dated Sep. 19, 2012 in U.S. Appl. No. 13/016,735. |
USPTO; Final Office Action dated Feb. 11, 2013 in U.S. Appl. No. 13/016,735. |
USPTO; Notice of Allowance dated Apr. 24, 2013 in U.S. Appl. No. 13/016,735. |
USPTO; Non-Final Office Action dated Apr. 4, 2012 in U.S. Appl. No. 13/030,438. |
USPTO; Final Office Action dated Aug. 22, 2012 in U.S. Appl. No. 13/030,438. |
USPTO; Notice of Allowance dated Oct. 24, 2012 in U.S. Appl. No. 13/030,438. |
USPTO; Non-Final Office Action dated Dec. 3, 2012 in U.S. Appl. No. 13/040,013. |
USPTO; Notice of Allowance dated May 3, 2013 in U.S. Appl. No. 13/040,013. |
USPTO; Notice of Allowance dated Sep. 13, 2012 in U.S. Appl. No. 13/085,698. |
USPTO; Non-Final Office Action dated Mar. 29, 2013 in U.S. Appl. No. 13/094,402. |
USPTO; Final Office Action dated Jul. 17, 2013 in U.S. Appl. No. 13/094,402. |
USPTO; Notice of Allowance dated Sep. 30, 2013 in U.S. Appl. No. 13/094,402. |
USPTO; Restriction Requirement dated May 8, 2013 in U.S. Appl. No. 13/102,980. |
USPTO; Office Action dated Oct. 7, 2013 in U.S. Appl. No. 13/102,980. |
USPTO; Final Office Action dated Mar. 25, 2014 in U.S. Appl. No. 13/102,980. |
USPTO; Notice of Allowance dated Jul. 3, 2014 in U.S. Appl. No. 13/102,980. |
USPTO; Non-Final Office Action dated Jul. 17, 2014 in U.S. Appl. No. 13/154,271. |
USPTO; Final Office Action dated Jan. 2, 2015 in U.S. Appl. No. 13/154,271. |
USPTO; Non-Final Office Action dated May 27, 2015 in U.S. Appl. No. 13/154,271. |
USPTO; Final Office Action dated Nov. 23, 2015 in U.S. Appl. No. 13/154,271. |
USPTO; Notice of Allowance dated Feb. 10, 2016 in U.S. Appl. No. 13/154,271. |
USPTO; Non-Final Office Action dated Oct. 27, 2014 in U.S. Appl. No. 13/169,951. |
USPTO; Final Office Action dated May 26, 2015 in U.S. Appl. No. 13/169,591. |
USPTO; Non-Final Office Action dated Sep. 1, 2015 in U.S. Appl. No. 13/169,951. |
USPTO; Non-Final Office Action dated Jun. 24, 2014 in U.S. Appl. No. 13/181,407. |
USPTO; Final Office Action dated Sep. 24, 2014 in U.S. Appl. No. 13/181,407. |
USPTO; Non-Final Office Action dated Jan. 2, 2015 in U.S. Appl. No. 13/181,407. |
USPTO; Final Office Action dated Apr. 8, 2015 in U.S. Appl. No. 13/181,407. |
USPTO; Non-Final Office Action dated Jan. 23, 2013 in U.S. Appl. No. 13/184,351. |
USPTO; Final Office Action dated Jul. 29, 2013 in U.S. Appl. No. 13/184,351. |
USPTO; Non-Final Office Action dated Jul. 16, 2014 in U.S. Appl. No. 13/184,351. |
USPTO; Final Office Action dated Feb. 17, 2015 in U.S. Appl. No. 13/184,351. |
USPTO; Non-Final Office Action dated Aug. 10, 2015 in U.S. Appl. No. 13/184,351. |
USPTO; Non-Final Office Action dated Sep. 17, 2014 in U.S. Appl. No. 13/187,300. |
USPTO; Final Office Action dated Apr. 15, 2015 in U.S. Appl. No. 13/187,300. |
USPTO; Non-Final Office Action dated Apr. 7, 2016 in U.S. Appl. No. 13/187,300. |
USPTO; Non-Final Office Action dated Oct. 1, 2012 in U.S. Appl. No. 13/191,762. |
USPTO; Final Office Action dated Apr. 10, 2013 in U.S. Appl. No. 13/191,762. |
USPTO; Notice of Allowance dated Aug. 15, 2013 in U.S. Appl. No. 13/191,762. |
USPTO; Non-Final Office Action dated Oct. 22, 2012 in U.S. Appl. No. 13/238,960. |
USPTO; Final Office Action dated May 3, 2013 in U.S. Appl. No. 13/238,960. |
USPTO; Non-Final Office Action dated Apr. 26, 2013 in U.S. Appl. No. 13/250,721. |
USPTO; Notice of Allowance dated Sep. 11, 2013 in U.S. Appl. No. 13/250,721. |
USPTO; Non-Final Office Action dated Jul. 2, 2014 in U.S. Appl. No. 13/283,408. |
USPTO; Final Office Action dated Jan. 29, 2015 in U.S. Appl. No. 13/283,408. |
USPTO; Non-Final Office Action dated Jun. 17, 2015 in U.S. Appl. No. 13/283,408. |
USPTO; Final Office Action dated Dec. 18, 2015 in U.S. Appl. No. 13/283,408. |
USPTO; Notice of Allowance dated Mar. 28, 2016 in U.S. Appl. No. 13/283,408. |
USPTO; Restriction Requirement dated Dec. 16, 2013 in U.S. Appl. No. 13/284,642. |
USPTO; Restriction Requirement dated Apr. 21, 2014 in U.S. Appl. No. 13/284,642. |
USPTO; Office Action dated Jul. 30, 2014 in U.S. Appl. No. 13/284,642. |
USPTO; Notice of Allowance dated Feb. 11, 2015 in U.S. Appl. No. 13/284,642. |
USPTO; Office Action dated Jan. 28, 2014 in U.S. Appl. No. 13/312,591. |
USPTO; Final Office Action dated May 14, 2014 in U.S. Appl. No. 13/312,591. |
USPTO; Non-Final Office Action dated Nov. 26, 2014 in U.S. Appl. No. 13/312,591. |
USPTO; Final Office Action dated Mar. 20, 2015 in U.S. Appl. No. 13/312,591. |
USPTO; Notice of Allowance dated May 14, 2015 in U.S. Appl. No. 13/312,591. |
USPTO; Non-Final Office Action dated Apr. 9, 2014 in U.S. Appl. No. 13/333,420. |
USPTO; Notice of Allowance dated Sep. 15, 2014 in U.S. Appl. No. 13/333,420. |
USPTO; Office Action dated Jan. 10, 2013 in U.S. Appl. No. 13/339,609. |
USPTO; Office Action dated Feb. 11, 2013 in U.S. Appl. No. 13/339,609. |
USPTO; Final Office Action dated May 17, 2013 in U.S. Appl. No. 13/339,609. |
USPTO; Office Action dated Aug. 29, 2013 in U.S. Appl. No. 13/339,609. |
USPTO; Final Office Action dated Dec. 18, 2013 in U.S. Appl. No. 13/339,609. |
USPTO; Notice of Allowance dated Apr. 7, 2014 in U.S. Appl. No. 13/339,609. |
USPTO; Non-Final Office Action dated Oct. 10, 2012 in U.S. Appl. No. 13/406,791. |
USPTO; Final Office Action dated Jan. 31, 2013 in U.S. Appl. No. 13/406,791. |
USPTO; Non-Final Office Action dated Apr. 25, 2013 in U.S. Appl. No. 13/406,791. |
USPTO; Final Office Action dated Aug. 23, 2013 in U.S. Appl. No. 13/406,791. |
USPTO; Non-Final Office Action dated Dec. 4, 2013 in U.S. Appl. No. 13/406,791. |
USPTO; Final Office Action dated Apr. 21, 2014 in U.S. Appl. No. 13/406,791. |
USPTO; Non-Final Office Action dated Jan. 14, 2013 in U.S. Appl. No. 13/410,970. |
USPTO; Notice of Allowance dated Feb. 14, 2013 in U.S. Appl. No. 13/410,970. |
USPTO; Non-Final Office Action dated Feb. 13, 2014 in U.S. Appl. No. 13/411,271. |
USPTO; Non-Final Office Action dated Jul. 31, 2014 in U.S. Appl. No. 13/411,271. |
USPTO; Final Office Action dated Jan. 16, 2015 in U.S. Appl. No. 13/411,271. |
USPTO; Notice of Allowance dated Oct. 6, 2015 in U.S. Appl. No. 13/411,271. |
USPTO; Restriction Requirement dated Oct. 29, 2013 in U.S. Appl. No. 13/439,528. |
USPTO; Office Action dated Feb. 4, 2014 in U.S. Appl. No. 13/439,528. |
USPTO; Final Office Action dated Jul. 8, 2014 in U.S. Appl. No. 13/439,528. |
UPPTO; Notice of Allowance dated Oct. 21, 2014 in U.S. Appl. No. 13/439,528. |
USPTO; Non-Final Office Action dated Apr. 11, 2013 in U.S. Appl. No. 13/450,368. |
USPTO; Notice of Allowance dated Jul. 17, 2013 in U.S. Appl. No. 13/450,368. |
USPTO; Office Action dated May 23, 2013 in U.S. Appl. No. 13/465,340. |
USPTO; Final Office Action dated Oct. 30, 2013 in U.S. Appl. No. 13/465,340. |
USPTO; Notice of Allowance dated Feb. 12, 2014 in U.S. Appl. No. 13/465,340. |
USPTO; Non-Final Office Action dated Oct. 17, 2013 in U.S. Appl. No. 13/493,897. |
USPTO; Notice of Allowance dated Mar. 20, 2014 in U.S. Appl. No. 13/493,897. |
USPTO; Office Action dated Dec. 20, 2013 in U.S. Appl. No. 13/535,214. |
USPTO; Final Office Action dated Jun. 18, 2014 in U.S. Appl. No. 13/535,214. |
USPTO; Notice of Allowance dated Oct. 23, 2014 in U.S. Appl. No. 13/535,214. |
USPTO; Non-Final Office Action dated Sep. 11, 2013 in U.S. Appl. No. 13/550,419. |
USPTO; Final Office Action dated Jan. 27, 2014 in U.S. Appl. No. 13/550,419. |
USPTO; Notice of Allowance dated May 29, 2014 in U.S. Appl. No. 13/550,419. |
USPTO; Non-Final Office Action dated Aug. 8, 2014 in U.S. Appl. No. 13/563,066. |
USPTO; Final Office Action dated Feb. 12, 2015 in U.S. Appl. No. 13/563,066. |
USPTO; Notice of Allowance dated Jun. 12, 2015 in U.S. Appl. No. 13/563,066. |
USPTO; Notice of Allowance dated Jul. 16, 2015 in U.S. Appl. No. 13/563,066. |
USPTO; Non-Final Office Action dated Nov. 7, 2013 in U.S. Appl. No. 13/565,564. |
USPTO; Final Office Action dated Feb. 28, 2014 in U.S. Appl. No. 13/565,564. |
USPTO; Non-Final Office Action dated Jul. 2, 2014 in U.S. Appl. No. 13/565,564. |
USPTO; Notice of Allowance dated Nov. 3, 2014 in U.S. Appl. No. 13/565,564. |
USPTO; Non-Final Office Action dated Aug. 30, 2013 in U.S. Appl. No. 13/570,067. |
USPTO; Notice of Allowance dated Jan. 6, 2014 in U.S. Appl. No. 13/570,067. |
USPTO; Non-Final Office Action dated Oct. 15, 2014 in U.S. Appl. No. 13/597,043. |
USPTO; Final Office Action dated Mar. 13, 2015 in U.S. Appl. No. 13/597,043. |
USPTO; USPTO; Notice of Allowance dated Aug. 28, 2015 U.S. Appl. No. 13/597,043. |
USPTO; Non-Final Office Action dated Feb. 12, 2015 in U.S. Appl. No. 13/597,108. |
USPTO; Final Office Action dated Jun. 1, 2015 in U.S. Appl. No. 13/597,108. |
USPTO; Non-Final Office Action dated Dec. 8, 2015 in U.S. Appl. No. 13/597,108. |
USPTO; Notice of Allowance dated Mar. 27, 2014 in U.S. Appl. No. 13/604,498. |
USPTO; Office Action dated Nov. 15, 2013 in U.S. Appl. No. 13/612,538. |
USPTO; Office Action dated Jul. 10, 2014 in U.S. Appl. No. 13/612,538. |
USPTO; Non-Final Office Action dated Apr. 15, 2015 in U.S. Appl. No. 13/646,403. |
USPTO; Final Office Action dated Oct. 15, 2015 in U.S. Appl. No. 13/646,403. |
USPTO; Notice of Allowance dated Feb. 2, 2016 in U.S. Appl. No. 13/646,403. |
USPTO; Non-Final Office Action dated May 15, 2014 in U.S. Appl. No. 13/646,471. |
USPTO; Final Office Action dated Aug. 18, 2014 in U.S. Appl. No. 13/646,471. |
USPTO; Non-Final Office Action dated Dec. 16, 2014 in U.S. Appl. No. 13/646/,471. |
USPTO; Final Office Action dated Apr. 21, 2015 in U.S. Appl. No. 13/646,471. |
USPTO; Non-Final Office Action dated Aug. 19, 2015 in U.S. Appl. No. 13/646,471. |
USPTO; Final Office Action dated Jan. 22, 2016 in U.S. Appl. No. 13/646,471. |
USPTO; Non-Final Office Action dated May 28, 2015 in U.S. Appl. No. 13/651,144. |
USPTO; Final Office Action dated Nov. 19, 2015 in U.S. Appl. No. 13/651,144. |
USPTO; Non-Final Office Action dated Nov. 19, 2015 in U.S. Appl. No. 14/659,437. |
USPTO; Non-Final Office Action dated Jun. 18, 2015 in U.S. Appl. No. 13/665,366. |
USPTO; Non-Final Office Action dated Apr. 3, 2015 in U.S. Appl. No. 13/677,133. |
USPTO; Notice of Allowance dated Aug. 4, 2015 in U.S. Appl. No. 13/677,133. |
USPTO; Office Action dated Jun. 2, 2014 in U.S. Appl. No. 13/677,151. |
USPTO; Final Office Action dated Nov. 14, 2014 in U.S. Appl. No. 13/677,151. |
USPTO; Notice of Allowance dated Feb. 26, 2015 in U.S. Appl. No. 13/677,151. |
USPTO; Non-Final Office Action dated Aug. 20, 2013 in U.S. Appl. No. 13/679,502. |
USPTO; Final Office Action dated Feb. 25, 2014 in U.S. Appl. No. 13/679,502. |
USPTO; Notice of Allowance dated May 2, 2014 in U.S. Appl. No. 13/679,502. |
USPTO; Non-Final Office Action dated Jul. 21, 2015 in U.S. Appl. No. 13/727,324. |
USPTO; Final Office Action dated Jan. 22, 2016 in U.S. Appl. No. 13/727,324. |
USPTO; Non-Final Office Action dated Oct. 24, 2013 in U.S. Appl. No. 13/749,878. |
USPTO; Non-Final Office Action dated Jun. 18, 2014 in U.S. Appl. No. 13/749,878. |
USPTO; Final Office Action dated Dec. 10, 2014 in U.S. Appl. No. 13/749,878. |
USPTO; Notice of Allowance Mar. 13, 2015 dated in U.S. Appl. No. 13/749,878. |
USPTO; Office Action dated Apr. 23, 2014 in U.S. Appl. No. 13/784,362. |
USPTO; Notice of Allowance dated Aug. 13, 2014 in U.S. Appl. No. 13/784,362. |
USPTO; Non-Final Office Action dated Dec. 19, 2013 in U.S. Appl. No. 13/784,388. |
USPTO; Notice of Allowance dated Jun. 4, 2014 in U.S. Appl. No. 13/784,388. |
USPTO; Restriction Requirement dated May 8, 2014 in U.S. Appl. No. 13/791,246. |
USPTO; Non-Final Office Action dated Sep. 19, 2014 in U.S. Appl. No. 13/791,246. |
USPTO; Final Office Action dated Mar. 25, 2015 in U.S. Appl. No. 13/791,246. |
USPTO; Non-Final Office Action dated Oct. 26, 2015 in U.S. Appl. No. 13/791,246. |
USPTO; Final Office Action dated Apr. 20, 2016 in U.S. Appl. No. 13/791,246. |
USPTO; Non-Final Office Action dated Nov. 6, 2015 in U.S. Appl. No. 13/791,339. |
USPTO; Final Office Action dated Apr. 12, 2016 in U.S. Appl. No. 13/791,339. |
USPTO; Non-Final Office Action dated Mar. 21, 2014 in U.S. Appl. No. 13/799,708. |
USPTO; Notice of Allowance dated Oct. 31, 2014 in U.S. Appl. No. 13/799,708. |
USPTO; Restriction Requirement dated Jun. 26, 2014 in U.S. Appl. No. 13/874,708. |
USPTO; Non-Final Office Action dated Oct. 9, 2014 in U.S. Appl. No. 13/874,708. |
USPTO; Notice of Allowance dated Mar. 10, 2015 in U.S. Appl. No. 13/874,708. |
USPTO; Notice of Allowance dated Apr. 10, 2014 in U.S. Appl. No. 13/901,341. |
USPTO; Notice of Allowance dated Jun. 6, 2014 in U.S. Appl. No. 13/901,341. |
USPTO; Non-Final Office Action dated Jan. 2, 2015 in U.S. Appl. No. 13/901,372. |
USPTO; Final Office Action dated Apr. 16, 2015 in U.S. Appl. No. 13/901,372. |
USPTO; Non-Final Office Action dated Jul. 8, 2015 in U.S. Appl. No. 13/901,400. |
USPTO; Final Office Action dated Jan. 14, 2016 in U.S. Appl. No. 13/901,400. |
USPTO; Notice of Allowance dated Aug. 5, 2015 in U.S. Appl. No. 13/901,372. |
USPTO; Non-Final Office Action dated Apr. 24, 2014 in U.S. Appl. No. 13/912,666. |
USPTO; Final Office Action dated Sep. 25, 2014 in U.S. Appl. No. 13/912,666. |
USPTO; Non-Final Office Action dated Jan. 26, 2015 in U.S. Appl. No. 13/912,666. |
USPTO; Notice of Allowance dated Jun. 25, 2015 in U.S. Appl. No. 13/912,666. |
USPTO; Non-Final Office Action dated Dec. 16, 2014 in U.S. Appl. No. 13/915,732. |
USPTO; Final Office Action dated Apr. 10, 2015 in U.S. Appl. No. 13/915,732. |
USPTO; Notice of Allowance dated Jun. 19, 2015 in U.S. Appl. No. 13/915,732. |
USPTO; Notice of Allowance dated Mar. 17, 2015 in U.S. Appl. No. 13/923,197. |
USPTO; Non-Final Office Action dated Sep. 12, 2014 in U.S. Appl. No. 13/941,134. |
USPTO; Notice of Allowance dated Jan. 20, 2015 in U.S. Appl. No. 13/941,134. |
USPTO; Restriction Requirement dated Apr. 30, 2015 in U.S. Appl. No. 13/941,216. |
USPTO; Non-Final Office Action dated Jul. 30, 2015 in U.S. Appl. No. 13/941,216. |
USPTO; Restriction Requirement dated Sep. 16, 2014 in U.S. Appl. No. 13/948,055. |
USPTO; Non-Final Office Action dated Oct. 30, 2014 in U.S. Appl. No. 13/948,055. |
USPTO; Non-Final Office Action dated Jun. 29, 2015 in U.S. Appl. No. 13/966,782. |
USPTO; Final Office Action dated Jan. 4, 2016 in U.S. Appl. No. 13/966,782. |
USPTO; Notice of Allowance dated Oct. 7, 2015 in U.S. Appl. No. 13/973,777. |
USPTO; Non-Final Office Action dated Feb. 20, 2015 in U.S. Appl. No. 14/018,231. |
USPTO; Notice of Allowance dated Jul. 20, 2015 in U.S. Appl. No. 14/018,231. |
USPTO; Restriction Requirement Action dated Jan. 28, 2015 in U.S. Appl. No. 14/018,345. |
USPTO; Non-Final Office Action dated Apr. 7, 2015 in U.S. Appl. No. 14/018,345. |
USPTO; Final Office Action dated Sep. 14, 2015 in U.S. Appl. No. 14/018,345. |
USPTO; Notice of Allowance dated Jan. 14, 2016 in U.S. Appl. No. 14/018,345. |
USPTO; Notice of Allowance dated Mar. 17, 2016 in U.S. Appl. No. 14/018,345. |
USPTO; Non-Final Office Action dated Mar. 26, 2015 in U.S. Appl. No. 14/031,982. |
USPTO; Final Office Action dated Aug. 28, 2015 in U.S. Appl. No. 14/031,982. |
USPTO; Notice of Allowance dated Nov. 17, 2015 in U.S. Appl. No. 14/031,982. |
USPTO; Non-Final Office Action dated Apr. 28, 2015 in U.S. Appl. No. 14/040,196. |
USPTO; Notice of Allowance dated Sep. 11, 2015 in U.S. Appl. No. 14/040,196. |
USPTO; Non-Final Action dated Dec. 3, 2015 in U.S. Appl. No. 14/050,150. |
USPTO; Non-Final Office Action dated Dec. 15, 2014 in U.S. Appl. No. 14/065,114. |
USPTO; Final Office Action dated Jun. 19, 2015 in U.S. Appl. No. 14/065,114. |
USPTO; Non-Final Office Action dated Oct. 7, 2015 in U.S. Appl. No. 14/065,114. |
USPTO; Notice of Allowance dated Feb. 22, 2016 in U.S. Appl. No. 14/065,114. |
USPTO; Non-Final Office Action dated Nov. 14, 2014 in U.S. Appl. No. 14/069,244. |
USPTO; Notice of Allowance dated Mar. 25, 2015 in U.S. Appl. No. 14/069,244. |
USPTO; Non-Final Office Action dated Sep. 9, 2015 in U.S. Appl. No. 14/090,750. |
USPTO; Final Office Action dated Feb. 11, 2016 U.S. Appl. No. 14/090,750. |
USPTO; Non-Final Office Action dated Mar. 19, 2015 in U.S. Appl. No. 14/079,302. |
USPTO; Final Office Action dated Sep. 1, 2015 in U.S. Appl. No. 14/079,302. |
USPTO; Non-Final Office Action dated Mar. 19, 2015 in U.S. Appl. No. 14/166,462. |
USPTO; Notice of Allowance dated Sep. 3, 2015 in U.S. Appl. No. 14/166,462. |
USPTO; Non-Final Office Action dated Nov. 17, 2015 in U.S. Appl. No. 14/172,220. |
USPTO; Office Action dated May 29, 2014 in U.S. Appl. No. 14/183,187. |
USPTO; Final Office Action dated Nov. 7, 2014 in U.S. Appl. No. No. 14/183,187. |
USPTO; Non-Final Office Action dated Mar. 16, 2015 in U.S. Appl. No. 14/183,187. |
USPTO; Final Office Action dated Jul. 10, 2015 in U.S. Appl. No. 14/183,187. |
USPTO; Non-Final Office Action dated Jan. 11, 2016 in U.S. Appl. No. No. 14/188,760. |
USPTO; Non-Final Office Action dated Oct. 8, 2015 in U.S. Appl. No. 14/218,374. |
USPTO; Final Office Action dated Feb. 23, 2016 in U.S. Appl. No. 14/218,374. |
USPTO; Non-Final Office Action dated Sep. 22, 2015 in U.S. Appl. No. 14/219,839. |
USPTO; Non-Final Office Action dated Nov. 25, 2015 in U.S. Appl. No. 14/219,879. |
USPTO; Final Office Action dated Mar. 25, 2016 in U.S. Appl. No. 14/219,839. |
USPTO; Non-Final Office Action dated Sep. 18, 2015 in U.S. Appl. No. 14/244,689. |
USPTO; Notice of Allowance dated Feb. 11, 2016 in U.S. Appl. No. 14/244,689. |
USPTO; Non-Final Office Action dated Oct. 7, 2015 in U.S. Appl. No. 14/246,969. |
USPTO; Non-Final Office Action dated Nov. 20, 2015 in U.S. Appl. No. 14/260,701. |
USPTO; Non-Final Office Action dated Aug. 19, 2015 in U.S. Appl. No. 14/268,348. |
USPTO; Non-Final Office Action dated Jan. 6, 2016 in U.S. Appl. No. 14/268,348. |
USPTO; Non-Final Office Action dated Oct. 20, 2015 in U.S. Appl. No. 14/281,477. |
USPTO1; Notice of Allowance dated Feb. 23, 2016 in U.S. Appl. No. 14/327,134. |
USPTO; Non-Final Office Action dated Feb. 12, 2015 in U.S. Appl. No. 14/457,058. |
USPTO; Final Office Action dated Jul. 14, 2015 in U.S. Appl. No. 14/457,058. |
USPTO; Non-Final Office Action dated Nov. 6, 2015 in U.S. Appl. No. 14/457,058. |
USPTO; Non-Final Office Action dated Nov. 24, 2015 in U.S. Appl. No. 14/498,036. |
USPTO; Final Office Action dated Apr. 5, 2016 in U.S. Appl. No. 14/498,036. |
USPTO; Non-Final Office Action dated Apr. 10, 2015 in U.S. Appl. No. 14/505,290. |
USPTO; Notice of Allowance dated Aug. 21, 2015 in U.S. Appl. No. 14/505,290. |
USPTO; Non-Final Office Action dated Jan. 16, 2015 in U.S. Appl. No. 14/563,044. |
USPTO; Final Office Action dated Jul. 16, 2015 in U.S. Appl. No. 14/563,044. |
USPTO; Notice of Allowance dated Oct. 15, 2015 in U.S. Appl. No. 14/563,044. |
USPTO; Notice of Allowance dated Dec. 2, 2015 in U.S. Appl. No. 14/563,044. |
USPTO; Non-Final Office Action dated Oct. 1, 2015 in U.S. Appl. No. 14/571,126. |
USPTO; Final Office Action dated Feb. 22, 2016 in U.S. Appl. No. 14/571,126. |
USPTO; Non-Final Office Action dated Nov. 25, 2015 in U.S. Appl. No. 14/598,532. |
USPTO; Non-Final Office Action dated Jan. 15, 2016 in U.S. Appl. No. 14/606,364. |
USPTO; Non-Final Office Action dated Mar. 3, 2016 in U.S. Appl. No. 14/622,603. |
USPTO; Non-Final Office Action dated Mar. 21, 2016 in U.S. Appl. No. 14/659,152. |
USPTO; Final Office Action dated Mar. 17, 2016 in U.S. Appl. No. 14/659,437. |
USPTO;Notice of Allowance dated Mar. 25, 2016 in U.S. Appl. No. 14/693,138. |
USPTO; Non-Final Office Action dated Mar. 30, 2016 in U.S. Appl. No. 14/808,979. |
USPTO; Non-Final Office Action dated Mar. 22, 2016 in U.S. Appl. No. 14/987,420. |
USPTO; Non-Final Office Action dated Mar. 16, 2015 in U.S. Appl. No. 29/447,298. |
USPTO; Notice of Allowance dated Jul. 6, 2015 in U.S. Appl. No. 29/447,298. |
USPTO; Notice of Allowance dated Nov. 26, 2014 in U.S. Appl. No. 29/481,301. |
USPTO; Notice of Allowance dated Feb. 17, 2015 in U.S. Appl. No. 29/481,308. |
USPTO; Notice of Allowance dated Jan. 12, 2015 in U.S. Appl. No. 29/481,312. |
USPTO; Notice of Allowance dated Apr. 30, 2015 in U.S. Appl. No. 29/481,315. |
USPTO; Notice of Allowance dated May 11, 2015 in U.S. Appl. No. 29/511,011. |
USPTO; Notice of Allowance dated May 11, 2015 in U.S. Appl. No. 29/514,153. |
USPTO; Notice of Allowance dated Dec. 14, 2015 in U.S. Appl. No. 29/514,264. |
PCT; International Search report and Written Opinion dated Nov. 12, 2010 in Application No. PCT/US2010/030126. |
PCT; International Preliminary Report on Patentability dated Oct. 11, 2011 Application No. PCT/US2010/030126. |
PCT; International Search report and Written Opinion dated Jan. 20, 2011 in Application No. PCT/US2010/045368. |
PCT; International Search report and Written Opinion dated Feb. 6, 2013 in Application No. PCT/US2012/065343. |
PCT; International Search report and Written Opinion dated Feb. 13, 2013 in Application No. PCT/US2012/065347. |
Chinese Patent Office; Office Action dated Jan. 10, 2013 in Application No. 201080015699.9. |
Chinese Patent Office; Office Action dated Jan. 12, 2015 in Application No. 201080015699.9. |
Chinese Patent Office; Office Action dated May 24, 2013 in Application No. 201080036764.6. |
Chinese Patent Office; Office Action dated Jan. 2, 2014 in Application No. 201080036764.6. |
Chinese Patent Office; Office Action dated Jul. 1, 2014 in Application No. 201080036764.6. |
Chinese Patent Office; Office Action dated Feb. 8, 2014 in Application No. 201110155056. |
Chinese Patent Office; Office Action dated Sep. 16, 2014 in Application No. 201110155056. |
Chinese Patent Office; Office Action dated Feb. 9, 2015 in Application No. 201110155056. |
Japanese Patent Office; Office Action dated Jan. 25, 2014 in Application No. 2012-504786. |
Japanese Patent Office; Office Action dated Dec. 1, 2014 in Application No. 2012-504786. |
Korean Patent Office; Office Action dated Dec. 10, 2015 in Application No. 10-2010-0028336. |
Taiwan Patent Office; Office Action dated Jul. 4, 2014 in Application No. 099110511. |
Taiwan Patent Office; Office Action dated Dec. 19, 2014 in Taiwan Application No. 099127063. |
Bearzotti, et al., “Fast Humidity Response of a Metal Halide-Doped Novel Polymer,” Sensors and Actuators B, 7, pp. 451-454, (1992). |
Bhatnagar et al., “Copper Interconnect Advances to Meet Moore's Law Milestones,” Solid State Technology, 52, 10 (2009). |
Buriak, “Organometallic Chemistry on Silicon and Germanium Surfaces,” Chemical Reviews, 102, 5 (2002). |
Cant et al., “Chemisorption Sites on Porous Silica Glass and on Mixed-Oxide Catalysis,” Can. J. Chem. 46, 1373 (1968). |
Chang et al. “Small-Subthreshold-Swing and Low-Voltage Flexible Organic Thin-Film Transistors Which Use HfLaO as the Gate Dielectric,” IEEE Electron Device Letters, 30, 2, IEEE Electron Device Society 133-135 (2009). |
Chen et al., “A Self-Aligned Airgap Interconnect Scheme,” IEEE International Interconnect Technology Conference, 1-3, 146-148 (2009). |
Choi et al., “Improvement of Silicon Direct Bonding using Surfaces Activated by Hydrogen Plasma Treatment,” Journal of the Korean Physical Society, 37, 6, 878-881 (2000). |
Choi et al., “Low Temperature Formation of Silicon Oxide Thin Films by Atomic Layer Deposition Using NH3/O2 Plasma,” ECS Solid State Letters, 2(12) 114-116 (2013). |
Crowell, “Chemical methods of thin film deposition: Chemical vapor deposition, atomic layer deposition, and related technologies,” Journal of Vacuum Science & Technology A 21.5, S88-S95 (2003). |
Cui et al., “Impact of Reductive N2/H2 Plasma on Porous Low-Dielectric Constant SiCOH Thin Films,” Journal of Applied Physics 97, 113302, 1-8 (2005). |
Dingemans et al., “Comparison Between Aluminum Oxide Surface Passivation Films Deposited with Thermal Aid,” Plasma Aid and Pecvd, 35th IEEE PVCS, Jun. 2010. |
Drummond et al., “Hydrophobic Radiofrequency Plasma-Deposited Polymer Films. Dielectric Properties and Surface Forces,” Colloids and Surfaces A, 129-130, 117-129 (2006). |
Easley et al., “Thermal Isolation of Microchip Reaction Chambers for Rapid Non-Contact DNA Amplification,” J. Micromech. Microeng. 17, 1758-1766 (2007). |
Ge et al., “Carbon Nanotube-Based Synthetic Gecko Tapes,” Department of Polymer Science, PNAS, 10792-10795 (2007). |
George et al., “Atomic Layer Deposition: An Overview,” Chem. Rev. 110, 111-131 (2010). |
Grill et al., “The Effect of Plasma Chemistry on the Damage Induced Porous SiCOH Dielectrics,” IBM Research Division, RC23683 (W0508-008), Materials Science, 1-19 (2005). |
Gupta et al., “Conversion of Metal Carbides to Carbide Derived Carbon by Reactive Ion Etching in Halogen Gas,” Proceedings of SPIE—The International Society for Optical Engineering and Nanotechnologies for Space Applications, ISSN: 0277-786X (2006). |
Heo et al., “Structural Characterization of Nanoporous Low-Dielectric Constant SiCOH Films Using Organosilane Precursors,” NSTI—Nanotech, vol. 4, 122-123 (2007). |
H.J. Yun et al., “Comparison of Atomic Scale Etching of Poly-Si in Inductively Coupled Ar and He Plasmas,” Korean Journal of Chemical Engineering, 24, 670-673 (2007). |
Jung et al., “Double Patterning of Contact Array with Carbon Polymer,” Proc. Of SPIE, 6924, 69240C, 1-10 (2008). |
Katamreddy et al., “Ald and Characterization of Aluminum Oxide Deposited on Si(100) using Tris(diethylamino) Aluminum and Water Vapor,” Journal of the Electrochemical Society, 153 (10) C701-C706 (2006). |
Kim et al., “Passivation Effect on Low-k S/Oc Dielectrics by H2 Plasma Treatment,” Journal of the Korean Physical Society, ″40, 1, 94-98 (2002). |
Kim et al., “Characteristics of Low Tempemure High Quality Silicon Oxide by Plasma Enhanced Atomic Layer Deposition with In-Situ Plasma Densification Process,” The Electrochemical Society, ECS Transactions, College of Information and Communication Engineerign, Sungkyunkwan University, 53(1), 321-329 (2013). |
King, Plasma Enhanced Atomic Layer Deposition of SiNx: H and SiO2, J. Vac. Sci. Technol., A29(4) (2011). |
Kobayshi et al. “Temperature Dependence of SiO2 Film Growth with Plasma-Enhanced Atomic Layer Deposition,” International Journal on the Science and Technology of Condensed Matter, 520, 3994-3998, (2012). |
Koo et al., “Characteristics of Al2O3 Thin Films Deposited Using Dimethylaluminum Isopropoxide and Trimethylaluminum Precursors by the Plasma-Enhanced Atomic-Layer Deposition Method,” Journal of Physical Society, 48, 1, 131-136 (2006). |
Koutsokeras et al. Texture and Microstructure Evolution in Single-Phase TixTa1-xN Alloys of Rocksalt Structure. Journal of Applied Physics, 110, 043535-1-043535-6, (2011). |
Krenek et al. “IR Laser CVD of Nanodisperse Ge—Si—Sn Alloys Obtained by Dielectric Breakdown of GeH4/SiH4/SnH4 Mixtures”, NanoCon, Brno, Czech Republic, Eu (2014). |
Kurosawa et al., “Synthesis and Characterization of Plasma-Polymerized Hexamethyldisiloxane Films,” Thin Solid Films, 506-507, 176-179 (2006). |
Lieberman, et al., “Principles of Plasma Discharges and Materials Processing,” Second Edition, 368-381. |
Lim et al., “Low-Temperature Growth of SiO2 Films by Plasma-Enhanced Atomic Layer Deposition,” ETRI Journal, 27 (1), 118-121 (2005). |
Liu et al., “Research, Design, and Experimen of End Effector for Wafer Transfer Robot,” Industrial Robot: an International Journal, 79-91 (2012). |
Mackus et al., “Optical Emission Spectroscopy as a Tool for Studying Optimizing, and Monitoring Plasma-Assisted Atomic Layer Deposition Processes,” Journal of Vacuum Science and Technology, 7787 (2010). |
Maeno, “Gecko Tape Using Carbon Nanotubes,” Nitto Denko Gihou, 47, 48-51. |
Maeng et al., “Electrical properties of atomic layer disposition Hf02 and HfOxNy on Si Substrates with Various Crystal Orientations,” Journal of the Electrochemical Society, 155, Department of Materials Science and Engineering, Pohang University of Science and Technology, H267-H271 (2008). |
Marsik et al., “Effect of Ultraviolet Curing Wavelength on Low-k Dielectric Material Properties and Plasma Damage Resistance,” Sciencedirect.com, 519, 11, 3619-3626 (2011). |
Moeen, “Design, Modelling and Characterization of Si/SiGe Structures for IR Bolometer Applications,” KTH Royal Institute of Technology. Information and Communication Technology, Department of Integrated Devices and Circuits, Stockholm Sweden (2015). |
Morishige et al., “Thermal Desorption and Infrared Studies of Ammonia Amines and Pyridines Chemisorbed on Chromic Oxide,” J.Chem. Soc., Faraday Trans. 1, 78, 2947-2957 (1982). |
Mukai et al., “A Study of CD Budget in Spacer Patterning Technology,” Proc. Of SPIE, 6924, 1-8 (2008). |
Nogueira et al., “Production of Highly Hydrophobic Films Using Low Frequency and High Density Plasma,” Revista Brasileira de Aplicacoes de Vacuo, 25(1), 45-53 (2006). |
Novaro et al., “Theoretical Study on a Reaction Pathway of Ziegler-Natta-Type Catalysis,” J. Chem. Phys. 68(5), 2337-2351 (1978). |
Radamson et al.,“Growth of Sn-alloyed Group IV Materials for Photonic and Electronic Applications”, Manufacturing Nano Structures, 5, 129-144. |
Schmatz et al., “Unusual Isomerization Reactions in 1.3-Diaza-2-Silcyclopentanes,” Organometallics, 23, 1180-1182 (2004). |
Scientific and Technical Information Center EIC 2800 Search Report dated Feb. 16, 2012. |
S.D. Athavale et al., “Realization of Atomic Layer Etching of Silicon”, Journal of Vacuum Science and Technology B, 14, 3702-3705 (1996). |
Sham Ma et al., “PDL Oxide Enabled Doubling,” Proc. Of SPIE, 6924, 69240D, 1-10 (2008). |
Varma, et al., “Effect of Metal Halides on Thermal, Mechanical, and Electrical Properties of Polypyromelitimide Films,” Journal of Applied Polymer Science, 32, 3987-4000, (1986). |
Wirths, et al, “SiGeSn Growth tudies Using Reduced Pressure Chemical Vapor Deposition Towards Optoeleconic Applications,” This Soid Films, 557, 183-187 (2014). |
Yun et al., “Behavior of Various Organosilicon Molecules in Pecvd Processes for Hydrocarbon-Doped Silicon Oxide Films,” Solid State Phenomena, 124-126, 347-350 (2007). |
Number | Date | Country | |
---|---|---|---|
20160240367 A1 | Aug 2016 | US |